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ABSTRACT 
Three-dimensional polymeric scaffolds have been widely used in tissue engineering for 
protein delivery. Scaffolds fabricated with different biomaterials and structures display various 
functions in protein delivery. A microsphere based delivery system is one sophisticated method. 
In this research, the potentials of alginate microspheres as protein carriers were tested. Alginate 
microspheres were prepared by a water-in-oil emulsion external gelation technique and loaded 
with bovine serum albumin (BSA) or DyLight 800 dye-labeled rabbit immunoglobulin G (IgG). 
Chitosan coated protein-loaded alginate microspheres were also prepared. The effects of process 
parameters on microsphere size, size distribution, encapsulation efficiency, and in vitro protein 
release profiles were investigated. Scanning electron microscopic photos showed that high 
dispersing force and high calcium chloride concentration produce small and uniform alginate 
microspheres with spherical shape and smooth surface. The release profiles indicated that BSA 
release from large and heterogeneous alginate microspheres was rapid and had a large initial 
burst release, and IgG release from small and homogeneous microspheres was slower and had 
lower initial burst release. Chitosan coating caused slower protein release compared to uncoated 
alginate microspheres in all cases. Protein-loaded microspheres were incorporated into alginate 
cylindrical scaffolds by long-term moulding in tubing for BSA or by fast gelation extruded from 
tubing for IgG. The scaffolds contained dried BSA loaded microspheres prepared using either 
protein incorporation or incubation methods, or with wet IgG-loaded microspheres with different 
concentrations. The release studies of BSA indicated that dried microspheres provided fast 
release possibly. The IgG release from scaffolds illustrated that chitosan coated IgG 
microspheres had more prolonged release profiles, and fast gelation of scaffolds could 
potentially eliminate protein loss during long-term gelation. All release profiles of scaffolds 
demonstrated that the initial burst effect was diminished and the release was extended by using a 
delivery system in which microspheres were incorporated into larger scaffolds. These prepared 
alginate microspheres and microsphere-incorporated scaffolds have been proven to have abilities 
of carrying and releasing proteins. Their applications toward delivery of functional proteins at 
the target site in patients for therapeutic purposes should be considered.  
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Chapter 1. Introduction 
1.1. Protein delivery in tissue engineering 
Tissue engineering focuses on developing strategies to regenerate or repair damaged 
tissues or organs in patients. Numerous methods have been developed and tested in vitro and in 
vivo with the aim of either stimulating regrowth of damaged tissues or constructing new 
engineered man-made tissues. Regeneration of functional tissues and incorporation of new 
tissues require adhesion, migration, proliferation, and organization of new and old cells at the 
injured site. In order to maintain and regulate the complex cellular activities, delivery of 
signalling proteins, functional peptides, and therapeutic drugs may be needed. In recent years, 
progress in tissue engineering allows delivery of functional and active proteins to act as chemical 
cues for desired biological purposes.  
Numerous proteins have been used in tissue engineering to serve a variety of functions. 
Proteins such as insulin, other hormones, and synthetic vaccines, have been widely used to 
manage poorly controlled diseases [1-3]. Growth factors are one type of protein that have 
abilities to regulate cell signalling, which can stimulate or inhibit growth of cells. Delivery of 
growth factors has become a valuable tool for directing cell proliferation, differentiation, 
migration, and angiogenesis in tissues [4-7]. The use of synthetic or conjugated peptides has also 
been proven to effectively guide and facilitate cellular activities owing to their improved 
penetration abilities into cells [8-10]. In order to exert the advantages of functional and 
therapeutic proteins in regenerative medicine, a suitable delivery system is required.  
Delivery techniques used in tissue engineering generally involve incorporating desired 
proteins into polymeric matrices. Key parameters that should be considered when designing a 
protein-delivery vehicle include localization of delivered proteins, targeting appropriate cells, 
optimal time period for protein administration, and appropriate doses of protein needed at 
different times. The delivery mechanism should be carefully designed to achieve regulated 
protein release over preferred time intervals.  
Protein release depends on the physicochemical and chemical properties of the polymer 
that are used to construct the carrier matrices as well as on the matrix structures. One of the 
fundamental release mechanisms is polymer-degradation-induced protein release. Hydrolytic or 
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enzymatic degradation of matrix polymers leads to cleavage of chemical bonds in matrix 
networks, which cause detachment of proteins from the internal networks. Another release 
mechanism is by diffusion of ions and molecules from polymeric matrices through the internal 
and external pores of the matrices. Many types of engineered delivery systems have been 
developed by utilizing different release mechanisms including the two mentioned above. A few 
types of these devices that are often used in tissue engineering are described as follows. 
Early drug reservoir systems were designed by surrounding a compact drug core with a 
polymer membrane or coating. This type of system is usually made of biocompatible but non-
degradable polymers [11]. Therefore, the drug release is dependent on the diffusion of the drug 
through the matrices. The rate of drug release is controlled by altering the size of the system and 
manipulating the drug concentration at the inner surface of the enclosed membrane [12]. The 
diffusion of drugs from these systems is normally slow, and can last for years. However, any 
unwanted rupture in the coating surfaces can cause a sudden increase in drug concentration, 
which potentially has toxic side effects for patients. Also, surgery can sometimes be required to 
remove the non-degradable system after drugs have been released. 
Polymer matrices that incorporate uniformly distributed proteins are also commonly used 
for protein delivery. Both biodegradable and non-biodegradable polymers have been used to 
fabricate this type of delivery system. In the case of non-degradable polymer matrices, the 
release relies on the diffusion of proteins throughout the solid matrix networks. The diffusion 
rate of proteins is regulated by the thickness and porosity of the matrix, the initial loading 
concentration of proteins, and the solubility of the protein [13]. Molecules near the surface 
diffuse out first, while those trapped deeper inside the matrix must overcome the constrictions of 
interconnected cavities within the matrices to move near the surface [14]. It has been reported 
that the protein release rate from a non-degradable poly(ethylene-vinyl acetate) matrix increases 
as the total loading increases, and large proteins have difficulties diffusing through the solid 
matrices [14]. Similar to the reservoir systems, non-degradable matrices need to be surgically 
removed from the implanted site.  
The biodegradable polymer matrices, on the other hand, are more applicable to human 
patients. Protein release from biodegradable matrices is not only dependent on the diffusion of 
protein, but also on the degradation rate of the polymers. Biodegradable polymers, such as 
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poly(lactide-co-glycolide) (PLG), poly(glycolic acid) (PGA), poly(lactic acid) (PLA), and 
poly(lactic-co-glycolic acid) (PLGA), poly(caprolactones) (PCL), have become attractive 
polymers for protein delivery [15]. The degradation process of these materials involves 
hydrolysis of polymer backbones into non-toxic monomers. The protein release rate could be 
controlled by changing the degradation rate of polymers, which can be achieved by chemical 
modification of polymers [7]. 
The third common protein delivery method is accomplished through protein loaded 
hydrogels. A hydrogel can be fabricated into many geometrical configurations, for example, 
cylinders, slabs, disks, or spheres. The following section focuses on the use of hydrogel 
microspheres, which are referred to as macro-gels. Hydrogels made with synthetic and natural 
polymers usually have a porous surface and a complex internal network. The swelling property 
of hydrogels in water allows free movement of proteins throughout cavities in hydrogels. The 
rate of protein release from a hydrogel might be regulated by controlling the degree of hydration, 
the permeability, the pore size, the porosity, and increasing or decreasing the ionic or covalent 
interactions between proteins and hydrogels. Proteins could be loaded into hydrogels before or 
after scaffold preparation; each method has its own benefits and drawbacks.  Incorporating 
proteins before scaffold construction requires hydrophilic biomaterials and non-toxic 
crosslinking formulations. Proteins can be evenly distributed in polymer solution and embedded 
in hydrogel matrices after crosslinking in this pre-loading method. However, only limited 
numbers of polymers and crosslinker can be used, since harsh preparation processes can destroy 
the stability and bioactivity of proteins. For instance, localized growth factor delivery was 
achieved by mixing growth factor protein with alginate solution then ionically gelling the 
mixture to form hydrogels. A previous study [16] showed that growth factors delivered in vivo 
have the ability to improve angiogenesis in tissues. On the other hand, incorporating proteins 
after formation of a hydrogel involves deposition and adsorption of proteins onto internal and 
external surfaces of hydrogels. This technique has the advantages of allowing optimization of 
hydrogel properties without compromising protein bioactivity. However, the quantity of protein 
loading that is achieved relies mainly on the chemical interaction and adsorptive properties of the 
protein and of the hydrogel surface. For example, protein which is ionically bonded to gelatin 
hydrogels can be controllably released according to the biodegradation rate of the gelatin 
hydrogels, which is in turn regulated by the extent of crosslinking of the hydrogels [17]. 
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Although the rate and time span of protein delivery by hydrogels have a high dependence on the 
biomaterial composition and the construct of matrices, hydrogels are considered to have great 
potential as a protein delivery system because they are amenable to careful modifications and 
manipulations.  
1.2. Three-dimensional tissue scaffolds 
Tissue engineering has great potential in the development of strategies to restore tissue 
and cellular functions for tissues with limited regeneration ability. A revolutionary approach in 
tissue engineering to regenerate or repair tissue after injury is to use bioengineered three-
dimensional polymer scaffolds. Such scaffolds have the ability to delivery growth factors, 
nutrients, and even living cells to the injured site, and also to provide mechanical strength to 
improve tissue development. The design of scaffolds suitable for tissue regeneration should meet 
the requirements or criteria of specific tissue types, as identified in the literature. The material 
property of the scaffolds is one critical factor. The scaffold materials should be biocompatible 
and not provoke any immune response in the tissue. The degradation profiles of the scaffold 
materials, which are linked to their physical and chemical properties, have to be easily adjusted 
or controlled to conform to the desired time span, but at the same time should provide the 
mechanical properties that are needed to support tissue growth. A desired material should also 
have the appropriate surface chemistry for cell attachment and proliferation. The micro- and 
macro- structures of scaffolds are also important factors dominating the functions of scaffolds. 
The macro-structure of scaffolds needs to be adjustable to a variety of configurations to fit the 
shape of interest. The porous surface and interconnected internal network of scaffolds should 
allow nutrient transport for cell survival, cell signalling, and ingrowth of vasculature and other 
tissues components. Scaffold properties should be tailored to the type of tissue to be regenerated. 
The microstructure or internal structure of scaffolds should be optimized to match the 
morphology and the growth properties of the tissues. For example, nerve regrowth requires 
longitudinal guidance, which is made possible by scaffolds with longitudinally orientated porous 
microstructure [18, 19]. 
Numerous attempts have been made to construct scaffolds that mimic the structure and 
biological functions of extracellular matrix (ECM), which is believed to have an optimal 
microenvironment for cell communication and cell signalling leading to regeneration of 
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functional tissues. Another function of ECM-mimicking scaffolds is to reduce the mechanical 
stress at the tissue-scaffold interface until the tissue is fully regenerated. Scaffolds utilizing both 
naturally derived polymers and biodegradable synthetic polymers have been widely used for 
tissue engineering applications. Many synthetic polymers have been used as scaffold materials, 
such as, PLA, PGA, PLG, PLGA, PCL, polypeptides, polyethylene glycol (PEG), and ceramics. 
Artificial polypeptides can be engineered to have desired amino acid sequences and structures, 
which allows modifications in scaffold stiffness and degradation rate [20]. Polyesters, including 
PLA, PGA, and PLGA, can be manipulated to produce different external and internal structures, 
and have been shown to have a good ability to promote cell attachment and long-term survival 
[21-24]. Porous scaffolds consisting of inorganic materials like ceramics and bioglass have great 
potential in bone tissue engineering due to their mechanical properties [25-27]. Naturally derived 
polymers have some biochemical properties that are very similar to the macromolecules 
produced by mammals, and therefore have the advantage of being recognized by the biological 
environment. However, technological manipulation of natural polymers is more complicated 
than it is for most synthetic polymers due to their complex structures.  
The degradation mechanisms of naturally derived polymers are hydrolysis and/or 
biodegradation by enzymes produced by the host. These degradation mechanisms have two 
aspects. The advantage is that the degradation products can be excreted or resorbed by the 
metabolic processes of the host. This means that undegraded natural polymers can continue to 
offer specific biological functions over a period of time. The disadvantage is that the rate of 
degradation needs to be carefully controlled to allow the polymers to fulfill their biological 
functions within scaffolds within an optimal time frame. Techniques for controlling the 
degradation rate of natural polymer scaffolds have been studied, such as chemical crosslinking or 
structural modification of the scaffold matrix material.  
The protein-based polymers, collagen, elastin, and fibrin, are considered to be superior 
biomaterials for scaffold design, since these proteins are often a main component of the ECM in 
many tissues. The ability of collagen and its derivatives to form sponge-like and gelatinous 
structures provide ECM-mimicking matrices for cell attachment and ingrowth, and their low 
physical strength has been improved by chemical crosslinking [28-30]. Because of its natural 
adhesive properties, the blood clot protein fibrin has gained a great deal of attention for use in 
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fabrication of tissue repair scaffolds. Fibrin forms gels through polymerization of fibrinogen in 
the presence of the protease enzyme thrombin, and gel degradation rate can be controlled by 
altering the concentration of a protease inhibitor. It has been reported that fibrin gels can promote 
cell migration, proliferation, and differentiation [31-33].  
The polysaccharide-based polymers, such as hyaluronic acid (HA), chitosan, and alginate, 
are popular biomaterials, but their cell adhesive properties are usually lower than those of the 
protein-based polymers. HA is an acidic glycosaminoglycan commonly present in ECM, which 
can regulate cell motility and mediate cell differentiation. Various chemically modified HA 
derivatives have been developed to improve mechanical strength and cell attachment [34-36]. 
Chitosan has a structure similar to natural glycosaminoglycans, and can be degraded by 
chitosanase and lysozyme [37]. Chitosan is capable of forming porous scaffolds by ionic or 
chemical crosslinking, and its ability to promote cell attachment has been enhanced by 
combining it with proteins [38-40] or by covalently modifying the sugar residues along the 
chitosan backbone [41]. Alginate from brown algae has similar biochemical properties to 
chitosan, and could also be used as an efficient biomaterial for scaffold construction. However, 
alginate has lower biocompatibility with a mammalian host, which reduces its ability to promote 
cell differentiation, proliferation, and attachment [42, 43]. Nonetheless, the easy and fast gelation 
feature of alginate still attracts much attention for tissue engineering applications [44-46].  
A wide range of synthetic and natural polymers has been explored for their abilities to 
construct three-dimensional scaffolds in tissue engineering. To fabricate a functional scaffold, 
the mechanical, chemical, and physicochemical features of the scaffolds that are produced have 
to be suitable for the type of tissue to be regenerated and for the biological environment into 
which they will be implanted. The practical advantages of a porous three-dimensional scaffold 
are undeniable, and with careful design, they have great potential to guide cells toward 
successful tissue regeneration.  
1.3. Microspheres as protein carriers 
One way of delivering bioactive molecules and achieving sustained release is the use of 
microsphere-based delivery systems [47-49]. Microspheres used as a protein delivery system 
should encapsulate the desired amount of protein, protect the integrity of protein functions, 
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induce no immune responses, and transport intact proteins to the targeted sites. Materials used in 
the fabrication of microspheres are nowadays biodegradable polymers, since surgical removal of 
delivery devices is not preferred. Several methods have been developed to prepare biodegradable 
microspheres. The preparation techniques have effects on the properties of microspheres and 
thus different techniques should be selected for different purposes. Techniques that have been 
used for microsphere preparation include emulsion, spray drying, phase separation, microfluidic 
preparation, self-assembly of supramolecules, and various polymerization techniques. The most 
popular current methods for preparing protein-loaded microspheres are the emulsion-based 
method and spray drying. 
To encapsulate hydrophilic proteins, one step emulsion water-in-oil (w/o), or double 
emulsion water-in-oil-in-water (w/o/w) techniques are often used. In the w/o emulsion process 
[50, 51], aqueous protein/polymer solution is dispersed in a continuous organic phase containing 
oil-soluble surfactants, while the emulsion solution is being intensively stirred, homogenized, or 
sonicated. The aqueous droplets that are formed in the continuous phase are solidified by adding 
a water soluble crosslinker for the polymer. In some cases, emulsion droplets are physically 
solidified by using heat. The solidified microgels or microspheres are washed by a solvent, 
detergent, or water to remove organic phase chemicals and surfactants. The formation of stable 
emulsion droplets is critical for producing microspheres. Using appropriate surfactants or 
emulsifiers helps to reduce the surface tension between the dispersed aqueous droplets and the 
hydrophobic continuous phase [52].  
For the production of very small microspheres, microemulsion is required, meaning 
formation of thermodynamically stable micellar droplets in the micron or submicron size range 
[53]. This microemulsion is achieved by using a surfactant concentration that is above its critical 
micelle concentration to prevent coalescence of micelles [52-54]. Protein-loaded microspheres 
have been prepared by this technique. A recent study showed that nanogels of chemically 
modified HA with a mean diameter of 200 nm were prepared using w/o techniques. The HA 
nanogels were used to entrap RNA, and were transported into cells successfully [55]. However, 
the spherical shape of these nanogels was not determined. In an earlier study, alginate 
microspheres were prepared by dispersing alginate solution in n-octanol containing hydrogenated 
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casteroil 60, and protein entrapping alginate microspheres with mean diameter of less than 5 µm 
were produced [56].  
The limitation of the water-in-oil technique is that only highly water soluble polymers 
can be used. In order to use hydrophilic polymers, w/o/w methods have to be employed to 
encapsulate proteins. In this method, a hydrophilic protein solution is dispersed in a polymer 
dissolved in organic solvent to create a w/o emulsion, and then this primary emulsion is 
dispersed into a large volume of aqueous solution containing water soluble surfactants [57]. The 
organic solvent can be removed by heat, vacuum, or solvent extraction. This method allows the 
use of various synthetic polymers for protein encapsulation, which have more potential for the 
introduction of chemical modifications.  
One possible problem for the w/o/w technique is the danger of denaturation of proteins, 
since the protein solution is directly dispersed in organic solvents. A copolymer of PCL and 
PLGA was used to prepare BSA-loaded microspheres with reasonable high encapsulation 
efficiency [58]. In this study, it was shown that protein release kinetics had a high dependence on 
the porosity of the microsphere surface, the internal structure of the microspheres, and the 
protein distribution inside the microsphere matrices. Emulsion techniques were also used to 
prepare PLGA, PLLA and PCL nanospheres with diameters ranging from 80 to 150 nm [59]. 
The results from this study showed that the polymer type and the surfactant amount and type all 
have effects on the size and size distribution of PLGA, PLLA and PCL nanospheres. In all 
emulsion techniques for preparing protein-loaded microspheres, the post-emulsion process to 
remove surfactant and organic residues by washing, heating, or solvent extraction could 
potentially damage or extract entrapped or encapsulated proteins from the porous microspheres. 
Nevertheless, one study suggested that the native confirmation of proteins could be stabilized by 
adding stabilizing excipients during the mixing of proteins and organic solvents in double 
emulsion techniques [60]. Another drawback of emulsion techniques is that of protein leakage 
during the dynamic emulsion process, which causes low encapsulation efficiency. The most 
important disadvantage is that the emulsion technique has a large reliance on the polymer 
properties and preparation parameters, which limits the number of polymers that can be used. 
Cautious investigation of these formulation parameters is needed. 
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The spray drying technique involves atomization of a dispersion of protein and polymer 
in a stream of hot air. Lyophilized protein is evenly suspended in organic polymer solution, and 
then the solution is atomized to small droplets in heated air. The small droplets containing 
proteins and polymers are solidified by quick solvent evaporation, followed by removal of 
organic solvent residues under vacuum. When hydrophilic protein/polymer is used, the aqueous 
solution is pre-mixed with crosslinker, and a fine mist of this solution is created by the atomizer. 
Typically, the diameters of microspheres formed by this method are in the micron and submicron 
range, depending upon the atomizing conditions. The particle size and size distribution can be 
controlled in this type of technique, and the results are highly reproducible. Chitosan has been a 
popular aqueous polymer used to prepare spray dried microspheres due to its fast ionic gelation 
property. Chitosan microspheres with diameters ranging from 6-9 µm were produced, and 
variation of the degree of crosslinking of chitosan was able to change the sphericity of the 
resultant particles [61]. Smaller chitosan microspheres ranging from 2-6 µm were fabricated by 
varying the preparation parameters [62]. In another study, insulin-encapsulating chitosan 
nanoparticles were prepared first by ionic gelation, then subsequently suspended in mannitol 
solution to form microspheres by the spray drying method. These nanoparticle aggregated 
chitosan microspheres had a smooth surface and spherical shape, with mean diameters from 3-4 
µm [63]. In one earlier study, recombinant human erythropoietin was encapsulated in PLG 
microspheres prepared either by spray drying or by the double emulsion technique [64]. This 
study suggested that spray dried PLG microspheres had a smaller size, yielded higher protein 
encapsulation efficiency, and contained less organic solvent residue compared to double 
emulsion methods. It has been demonstrated that microspheres produced by the spray drying 
method are small in size and narrow in size range. However, the heated air and drying process 
used in spray drying still impose a hazard on proteins, since proteins are likely to aggregate and 
denature in high temperature. 
The protein release mechanism of biodegradable microspheres is mainly dependent on 
polymer degradation, diffusion of proteins, and complexation between proteins and polymer 
matrices. Therefore, the rate of protein release could be regulated by chemically and physically 
engineering the polymer degradation rate, the permeability of the microspheres, the internal 
structure of microsphere matrices, and the interaction between proteins and matrix polymers. 
During release time, proteins at or near the surface of microspheres are initially released, 
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followed by slower release of proteins from the bulk or the core of microspheres depending upon 
the diffusion rate and distribution of proteins, and erosion and degradation of the microsphere 
core.  
A commonly observed problem with protein release from microspheres is the initial burst 
release, which is principally due to the rapid diffusion of proteins from the surface of 
microspheres constructed from both synthetic and natural polymers [65, 66]. This initial burst 
effect can be reduced by several methods. In one study, the initial burst release of nerve growth 
factor (NGF) protein from PLGA microspheres prepared by spray drying methods was reduced 
to about 1% and the NGF was released for a period of 14 days [67]. The sustained release of 
NGF was achieved by adding zinc acetate to form a complex with NGF, which stabilizes the 
protein structures, and by adding zinc carbonate to PLGA solution prior to microsphere 
preparation, which slows down the hydration rate of microspheres and closes the surface pores of 
microspheres due to swelling. Similarly, the release profile of encapsulated insulin-like growth 
factor-I protein from PLGA microspheres was changed from a pattern of high initial burst 
followed by a slow release to one of low initial burst followed by a rapid release, since the 
protein distribution and hydrophobicity of PLGA were changed [68]. Increasing the protein-
PLGA interactions by using additives and physically altering PLGA properties to reduce porosity 
of microspheres can also suppress initial burst effect and prolong the release time [69]. In the 
case of hydrophilic polymers, such as alginate and chitosan, modifying the microsphere surface 
and changing polymer compositions can help to reduce the initial burst effects. Alginate 
microspheres ionically coated with chitosan and polyethylene glycol were further covalently 
coated with chitosan and cellulose acetate phthalate, and initial release of heparin from the 
double coated alginate microspheres was moderately reduced as compared to microspheres with 
a single layer coating [70]. In another study, a decreased burst effect and sustained release of 
proteins from alginate beads was achieved by triply coating beads with high concentrations of 
polycations, polylysine or poly(vinyl amine) [71]. Coating BSA-loaded chitosan microspheres 
with hydrophobic polymers, such as paraffin oil and PLA, could decrease the porosity of 
microsphere surface, and thus lower protein initial release and increased release time [72]. 
Using appropriate microspheres as delivery devices can help stabilize the incorporated 
proteins, provide localized delivery, and achieve sustained release. However, there are some 
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challenges in preparing microspheres for optimal delivery of the proteins that are incorporated 
within them. Proteins as macromolecules have special three-dimensional structures, which 
directly affect the functions that they serve. Thus, maintaining the innate secondary, tertiary and 
quaternary structures of proteins during preparation and delivery process is extremely important 
for them to serve their biological functions. Since proteins can be digested by enzymes produced 
by the host, it is crucial to prevent proteins from unnecessary degradation until they reach their 
intended site of action. Therefore, mild process and formulation conditions are needed during 
protein encapsulation to avoid any loss of bioactivity. Another difficulty is to control the released 
dose at different periods over the time span of release. To solve this problem, the mechanism of 
protein release from different type of microspheres should be investigated thoroughly from 
chemical and physical points of view. Although the protein release kinetics may not be 
completely regulated, further research should be done to better understand and predict the release 
behaviours. To obtain the desired protein release profiles, the nature of polymer, polymer 
compositions, chemistry of crosslinking, properties of proteins, size of microspheres, and the 
surface and core properties of microsphere matrices should all be considered in designing protein 
release microspheres. 
1.4. Alginate microspheres in tissue engineering 
Alginate is a naturally occurring polymer derived from brown algae. The chemical 
structure of alginate is a linear unbranched polysaccharide containing alternating residues of 
1,4’-linked β-D-mannuronic aicd (M) and α-L-guluronic acid (G) [73]. The molecular weight 
and chemical constitution of alginate depend on the source from which the alginate is isolated 
[74, 75]. The proportion and sequence of M and G residues determine the properties of alginate.  
Alginate as a water soluble polymer can be gelled rapidly by using divalent cations 
except Mg2+. Cations commonly used to form alginate gels are Ca2+, Sr2+, or Ba2+. Although 
Ca2+ does not have the highest affinity toward alginate [76], it is commonly used due to its non-
toxicity and low cost. The water soluble alginate is in its sodium salt form, where the Na+ is 
ionically bonded to G blocks of alginate. During the gelation process of alginate, divalent cations 
replace the Na+ associated with carboxyl groups on G blocks and fill in the interchain cavities, 
consequently one alginate chain dimerizes with other chains in alternation to form a complex gel 
network [73]. The calcium induced gelation of alginate has been studied. The ionic bonding 
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between G blocks of one chain and Ca2+ leads to the formation of interchain junction zones, 
which result in a stable and insoluble gel of alginate [77, 78]. Since Ca2+ only form bonds with G 
blocks, the proportion and the sequence of G blocks in alginate affect the properties of gels 
formed [73, 79].  
Alginate gels have been tested for their biocompatibility. It has been reported that 
implanted alginate gels induced fibrosis in tissues [80], but other in vivo studies have shown that 
alginate does not provoke an inflammatory response [81]. In some cases, the impurity of alginate 
was found to be responsible for the inflammatory response and antigenic behaviour of alginate 
implants [81, 82]. Also, alginate polymer was shown to have mucoadhesion properties, which 
makes alginate a good candidate for drugs or proteins needed to be delivered via mucosal tissues 
[83]. However, the cell adhesion properties of alginate are poor; thus it does not promote cell 
attachment [42].  
Alginate beads formed by a calcium-induced gelation process have been widely used for 
tissue engineering applications, such as cell encapsulation, and nucleic acid, drug, and protein 
delivery. Large alginate beads can be produced by dropping alginate solution into calcium 
chloride (CaCl2) solution [84, 85]. The size of alginate beads formed by this method depends on 
the viscosity of the alginate solution, the size of the syringe, the distance between the needle and 
the surface of the CaCl2 solution, and the flow rate of alginate solution extrusion [86]. Alginate 
beads prepared by this method normally have diameters greater than 1 mm. This mild technique 
for large bead formation is particularly suitable for encapsulating living cells in alginate hydrogel 
[87, 88].  
Alternatively, alginate microbeads or microspheres used for protein encapsulation are 
commonly prepared by spray drying or emulsion techniques. The spray drying technique 
produces alginate microspheres by atomizing alginate solution to fine spherical droplets, which 
are further crosslinked by calcium ions [89-91]. As mentioned before, the emulsion technique 
involves dispersing alginate solution into an organic solution containing appropriate surfactants, 
followed by gelation or solidification process. The alginate micelles can be solidified internally 
or externally by using either calcium carbonate (CaCO3) or CaCl2 [92-96]. In the external 
gelation approach, the CaCl2 solution is slowly dropped into the emulsion after the formation of 
alginate droplets in the emulsion. In the case of internal gelation method, fine grains or 
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microcrystals of CaCO3 are evenly mixed with alginate solution prior to the emulsion processes, 
and then the solid CaCO3 distributed in alginate droplets is liquefied by adding an oil soluble 
acid, typically acetic acid.  
Due to the intrinsic differences in the gelation processes, the properties of alginate 
microspheres produced by each method vary. Alginate microspheres produced by the internal 
gelation method have homogenous internal structure but a porous surface, while the external 
gelation method provides compact surface structure but an unevenly distributed internal polymer 
network. The size and size distribution of alginate microspheres prepared by the emulsion 
method also vary depending upon the preparation parameters, such as the type of organic phase 
and surfactant and stirring speed. In a previous study, alginate solution was dispersed into 
silicone oil to prepare alginate microspheres by using the internal gelation method [97]. The 
average diameters of alginate microspheres were 489±32 µm and ranged from 120 to 1600 µm. 
Another earlier study used iso-octane containing Span 85 as the continuous organic phase to 
disperse alginate solution, and microspheres were gelled externally. The alginate microspheres 
prepared this way had spherical shapes and smooth surfaces, with diameters smaller than 150 µm 
but larger than 10 µm. A later study investigated the effects of different surfactants in iso-octane 
on the sizes of resultant alginate microspheres [66]. Alginate microspheres prepared using a high 
viscosity solution have diameters ranging from 1 to 150 µm. It was also found that using the iso-
octane/Span 85 emulsion formulation could make alginate microspheres with a mean diameter of 
7.6±0.1 µm for low viscosity alginate [66]. An attempt to produce small alginate microspheres 
used n-octanol as the organic phase and HCO-60 as a surfactant [56]. The resultant alginate 
microspheres had smooth surface and the diameters ranged from 0.5 to 5 µm.  
All calcium induced alginate gelation undergoes the same chemical reaction, which is the 
formation of an alginate network by crosslinking of G blocks. Thus, the mechanism of calcium-
alginate hydrogel biodegradation is the same, but the rate is different depending upon the 
chemical composition of alginate and the structure of the polymer network. Since mammals do 
not produce enzymes specifically for alginate, the degradation of alginate hydrogels is not 
enzymatic. The mechanism of alginate degradation is a hydrolysis or dissolution process, where 
crosslinking calcium ions are released from gels into the surrounding media. The large alginate 
chains remaining after the dissolution process are unlikely to be removed completely by the host, 
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because the molecular weights of commercial alginate are higher than the renal clearance 
threshold of the kidneys [98]. Both in vivo and in vitro studies have demonstrated that the 
calcium crosslinked unmodified alginate hydrogels degrades through ionic exchange of 
crosslinking calcium ions with monovalent ions from the media at neutral pH, which is an 
uncontrollable process [99, 100]. The uncontrollable exchange rate of calcium and monovalent 
ions could be problematic for regulating the release rate of encapsulants. The release rate of 
protein from alginate microspheres is mainly dependent on the dissolution rate of alginate and 
the diffusion rate of proteins. The dissolution rate of unmodified calcium-alginate gels, as 
mentioned, is difficult to control, but the degradation rate of chemically modified alginate can be 
controlled [99]. Also, the release of protein from alginate gels could be rapid because of the 
hydrophilic nature of alginate and the porous feature of hydrogels [101]. However, the diffusion 
rate of proteins could be reduced by increasing protein-gel interaction [70], coating gels to 
reduce permeability of microsphere surfaces [102], or regulating the internal gel structures [103].  
Alginate microspheres or nanospheres have attracted considerable attention as potential 
protein delivery systems. Calcium-alginate gels can be produced using relatively mild conditions, 
suitable for encapsulating and protecting proteins. An earlier study used alginate microspheres 
encapsulating nerve growth factor (NGF), fabricated using the single emulsion method, to treat 
degeneration of cholinergic neurons by implanting microspheres in the lesioned pia arachnoid 
vessels in the central nervous system of rats [104]. The immunocytochemical results of in vivo 
release studies showed that sustained release of NGF can prevent neuronal degeneration, and the 
microsphere delivery systems were comparable with installed cannulae. The protein release time 
can be extended by improving the protein-alginate interaction. An in vitro study encapsulated 
proteins with high isoelectric point (pI) into alginate microspheres and compared release profiles 
of high and low pI proteins [105]. The release of high pI protein was shown to be more 
prolonged than that of low pI protein from alginate microspheres due to the electric bonding 
between high pI proteins and alginate polymers [105]. Heparin binding vascular endothelial 
growth factor (VEGF) and basic fibroblast growth factor (bFGF) have been encapsulated into 
alginate microgels, and sustained releases of both proteins were observed in vitro [16]. These 
growth factor-loaded alginate gels were tested in vivo, and it was found that both growth factors 
were delivered subcutaneously and promoted angiogenesis in severe combined immunodeficient 
mice. In another study [106], bFGF protein was loaded into already formed heparin-alginate 
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microbeads by immersion, with an 80% encapsulation efficiency. The bFGF protein was 
delivered through these heparin-alginate microcapsules implanted in ischemic but viable 
unrevascularizable myocardium in patients undergoing coronary artery bypass graft surgery, and 
the results showed that using these microcapsules to deliver bFGF was a safe and feasible 
method.  
The poor cell adhesion property of alginate can be improved by coating alginate 
microspheres with cell adhesive proteins. Peptide-loaded alginate microspheres produced by the 
emulsion technique were covalently coated with human serum albumin [107]. This in vitro study 
using osteoblast cultures demonstrated that the protein coating reduced the release rate of 
peptides from alginate microspheres, and increased their cell adhesive properties.  
Sustained release can also be achieved by coating alginate microspheres with chitosan 
[71, 108-110]. The chitosan membrane around alginate microspheres decreases the swelling rate 
and gel erosion, and thus delays the protein diffusion throughout the gels. It was reported that 
sustained protein release can be achieved from chitosan coated alginate microspheres prepared 
with alginate with high molecular weight and high G unit contents, and chitosan with high 
molecular weight, large charge density, and appropriate coating concentrations [71, 108, 109, 
111, 112]. Alginate microspheres also have been coated with silk fibroin to improve mechanical 
stability and to prolong the time span of release [113], or with polylysine to form a diffusion 
barrier to encapsulants and to protect microspheres from hydrolytic enzymes [114, 115]. 
Since the size, size distribution, morphology, and swelling features of alginate 
microspheres have direct influences on the rate and time span of protein delivery, it is 
worthwhile to investigate how the preparation parameters used in the emulsion technique can 
change the physical properties of alginate microspheres. The emulsion technique has been 
demonstrated to create microspheres with good morphology. The emulsion system using liquid 
paraffin oil as a continuous phase and 0.5-4% of Span 80 as a surfactant was used to prepare 
chitosan microspheres. The smallest mean diameters were 297 µm when a stirring speed of 700 
rpm was used [116]. When the stirring speed was increased to 3000 rpm, the diameter of the 
chitosan microspheres produced by using 1% Span 80 in paraffin oil as continuous phase was 
10.2±0.21 µm [117]. It seems worthwhile to test the potential of the paraffin oil/span 80 
emulsion system to produce alginate microspheres in 50 mL of paraffin oil, since the paraffin 
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oil/Span 80 emulsion volume used in the past cases was large than 50 mL. Also, the factors that 
influence the size of alginate microspheres in this emulsion system need to be investigated. The 
feasibility of ionically crosslinking alginate microspheres using externally supplied CaCl2 during 
the emulsion process need to be studied.  
Since BSA has been used as a common small protein model in past studies, the use of 
BSA could help to establish the loading and release behaviour of alginate microspheres prepared 
using different methods. A few attempts have been made to create microsphere-incorporated 
scaffolds as a protein delivery device in order to extend and control the protein release [118, 119]. 
Therefore, the BSA-loaded alginate microspheres created by the paraffin oil/Span 80 emulsion 
system need to be studied to optimize the synthesis conditions. Also, BSA release profiles from 
microspheres embedded within alginate scaffolds need to be investigated. The results obtained 
from BSA-loaded alginate microspheres can be used to determine their functions as protein 
release system, and the release behaviours of microsphere-embedded alginate scaffolds can be 
used to assess their ability as a double release system. However, the use of large emulsion 
volume could not meet the practical needs of producing small quantity of microspheres with 
small amount of protein, and the use of BSA could not satisfy the need of establishing a release 
model for larger proteins. Since the effective dose of many large proteins is in the nanogram 
range, a procedure to encapsulate smaller amounts of large molecular weight protein in alginate 
microspheres need to be built. Based on the results obtained from BSA-loaded alginate 
microspheres, the emulsion/external gelation process needs to be refined to meet practical 
laboratory needs. Also, the total volume of emulsion mixture and the protein loading percentage 
need to be reduced. A larger protein, immunoglobulin G (IgG), was encapsulated in alginate 
beads by extruding alginate/IgG solution into CaCl2 solution in a previous study, but it was not 
commonly used as a protein release model to study microspheres prepared using the emulsion 
technique. It is also attractive to study the loading and release behaviours of IgG due to its 
unique quaternary structure. The release profiles of IgG from alginate microspheres produced in 
an optimized process and from scaffolds loaded with different amount of IgG-microspheres 
could provide helpful information for continuing future work on using such a system to deliver 
large proteins in a controlled manner in vivo. 
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1.5. Research objectives 
The aim of this research is to prepare alginate microspheres using an emulsion technique 
and investigate their potential as a protein delivery system. This study serves the goal of 
fabricating microparticles for sustained delivery of bioactive macromolecules as part of a tissue 
engineering strategy to improve tissue regeneration. 
Objectives: 
1. Examine the feasibility of using the emulsion technique to produce alginate microspheres. 
2. Study the ability to control microsphere size and size distribution by varying emulsion 
process parameters. 
3. Compare loading and encapsulation efficiency using incubation and incorporation 
methods of protein loading. 
4. Measure the release profile of two model proteins from alginate microspheres and 
analyze parameters that influence release rate. 
a. Protein loading methods 
b. CaCl2 concentration 
c. Chitosan coating 
d. Protein properties 
e. Release media 
5. Study the feasibility of embedding alginate microspheres into a large 3D alginate 
cylindrical scaffold matrix 
6. Investigate the release profiles of model proteins from microsphere-incorporated alginate 
cylindrical scaffolds and analyze influences of preparation parameters on protein release 
rate. 
a. Crosslinking process of alginate scaffolds 
b. Microsphere densities within scaffolds 
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1.6. Thesis organization 
This thesis consists of three major components, which are an introduction, description of 
the experimental preparation and characterization of protein loaded alginate microspheres and 
scaffolds, and comparative discussion and conclusions. 
The second chapter of the thesis presents the development and characterization of BSA-
loaded alginate microspheres and microsphere-incorporated alginate scaffolds. The use of the 
emulsion technique to create alginate microspheres was examined first. The effects of different 
preparation parameters on the morphology, size, and release profiles of microspheres were also 
examined. The profiles of release of BSA from alginate microspheres embedded in alginate 
scaffolds were measured, and the influences of microsphere densities in alginate scaffolds were 
studied.  
The third chapter demonstrates a scaled down preparation method for IgG-loaded 
alginate microspheres, which is more suitable for delivery of protein in microgram and nanogram 
scale. The feasibility of producing small alginate microspheres using different parameters in 
emulsion technique was examined. The release profiles of IgG from small alginate microspheres 
and the effects of chitosan coating on the release rate were analyzed. The release of IgG from 
small alginate microspheres embedded in alginate scaffolds was also investigated.  
A detailed and comparative discussion of results obtained from chapter 2 and 3 and 
conclusions are presented in chapter 4. The different parameters used in emulsion processes for 
producing alginate microspheres containing BSA and IgG were compared, and the factors 
influencing the morphology and size of alginate microspheres were addressed. The release 
profiles of two model proteins were compared and the parameters that influence the release rate 
were analyzed. The effects of different conditions used in release studies on release profiles of 
two models proteins were evaluated and the practical aspects of these conditions were discussed. 
Also, the use of microspheres incorporated within alginate scaffolds as a protein release device 
was assessed.  
The last chapter summarizes this research and recommends potential future work.  
19 
 
Chapter 2. Alginate microspheres for release of BSA 
2.1. Introduction 
Alginate microspheres have been widely used as delivery vehicles for macromolecules in 
vitro and in vivo due to their biocompatibility and non-toxicity [71, 87, 102, 120-122]. One 
common technique, water-in-oil emulsion [56, 95], is able to create microspheres at micro-level. 
The protein loaded in alginate microspheres is released at the destination site due to the 
degradation or erosion of microspheres. Therefore, the protein release kinetics is highly 
dependent on the degradation properties of alginate gels. In order to accomplish sustained protein 
release, coating microspheres with other material(s) can create a diffusion barrier to ion flux, 
thereby preserving ionic crosslinking [71, 110, 112]. In tissue engineering, the goal of delivering 
proteins is to provide proteins at a desired location in a controlled manner. The release of 
proteins could be retarded and localized using scaffolds containing protein encapsulated 
microspheres. In fact, microspheres incorporated into scaffolds can be used as polymeric 
delivery vehicles to deliver functional protein over a long period of time [123-126]. Microsphere 
incorporated polymeric scaffolds have the advantages of reducing the osmotic burst effect, 
increasing the local protein concentration, and controlling protein release rates, compared to 
protein-loaded porous microspheres alone [126, 127]. It has been found that the chemical and 
physical properties of microsphere and scaffolds influence the protein release kinetics [128]. 
Protein release is controlled by the diffusion-erosion process of microspheres and hydrogels, 
suggesting the release rate might be effectively controlled by optimizing the preparation 
parameters of microspheres and hydrogels.  
In the work presented in this chapter, alginate was used to synthesize alginate 
microspheres using the paraffin oil/Span 80 emulsion system, and BSA was selected as a model 
protein and loaded into alginate microspheres. The aim of the first part of the research is to 
construct a procedure for preparing BSA-loaded alginate microspheres using the chosen 
emulsion system. The release profile of protein from microspheres was examined in vitro, with a 
focus on the influence on the release profile of such factors as the crosslinker concentration, 
protein loading methods, and polymeric coating of microspheres. In addition, cylindrical alginate 
scaffolds were prepared with incorporated microspheres, and protein release profiles from 
different types of scaffold construct were also examined. 
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2.2. Materials and methods 
2.2.1. Materials 
Low-viscosity alginic acid sodium salt (A2158), middle-viscous chitosan, calcium 
chloride (CaCl2), bovine serum albumin (BSA), paraffin oil, and Span 80 were purchased from 
Sigma-Aldrich (Oakville, Canada). Alginate (A2158) has a mannuronic to guluronic acid ratio of 
1.67 and an average molecular weight of 50 kDa [129]. Dulbecco’s modified Eagle’s medium 
(DMEM) was obtained from Invitrogen (Burlington, Canada).  
2.2.2. Preparation of alginate microspheres 
Sodium alginate was dissolved in water to obtain a final alginate concentration of 5% 
(wt/vol). Microspheres were prepared by means of the modified emulsification and internal 
gelation methods [92, 120]. Briefly, the 5% alginate solution was dispersed into paraffin oil 
containing 5% Span 80 with a ratio of 1:4 (i.e., the volume of aqueous phase / the volume of oil 
phase); by stirring at 1200 rpm using a mechanical stirrer, and the emulsification process was 
continued for 30 minutes at room temperature.  Then, either 1% or 10% (wt/vol) of CaCl2 
solution was added slowly into the emulsion mixture. The mixture was then continuously stirred 
at 1200 rpm for two hours to permit gelation of microspheres with calcium cations, which was 
followed by the addition of 10 mL of 100% isopropyl alcohol to harden the microspheres that 
were formed. After stirring for 10 minutes, the microspheres were collected by centrifugation at 
an acceleration of 200 g for 10 minutes at room temperature. Subsequently, collected 
microspheres were washed twice with isopropyl alcohol and water, and lyophilized for 24 hours 
in a freeze dryer (Labconco Co.). Alginate microspheres were prepared in triplicate for the 
sequential tests.   
2.2.3. Preparation of chitosan-coated alginate microspheres 
Chitosan was dissolved in 2% acetic acid to a concentration of 0.1%, the pH value of the 
obtained chitosan solution was adjusted to 5 by adding 1M NaOH. Freeze-dried alginate 
microspheres prepared according to the above methods were dispersed into 0.1% chitosan 
solution containing 5 mM CaCl2, and were then gently shaken for 1 hour at room temperature to 
allow adsorption of cationic chitosan molecules onto the anionic surface of alginate microspheres. 
21 
 
The chitosan-coated microspheres were collected by centrifugation, washed twice with water, 
and then lyophilized. 
2.2.4. Physical characterization of alginate microspheres 
The size of microspheres was measured using an optical microscope (Akioskop) 
equipped with a camera. The freeze-dried microspheres were suspended in water and then 
photographed immediately. The images of microspheres were analyzed by Northern Eclipse 
image analyzing software (Empix Imaging, Mississauga, ON). The diameter of microspheres 
was averaged from one hundred sample microspheres in each batch, and two batches from each 
condition were analyzed. 
The shape and morphology of microspheres were also visualized by scanning electron 
microscopy (SEM). The freeze-dried microspheres were deposited on a conductive tab pressed 
on to a specimen holder and coated with gold under vacuum. The SEM photographs were 
obtained using a Philips 505 scanning electron microscope. 
2.2.5. Preparation of BSA-loaded alginate microspheres 
2.2.5.1. Incorporation method - loading BSA during emulsion 
BSA protein were added into 5% alginate solution, and mixed for 10 minutes by using a 
mechanical stirrer. Subsequently, the alginate-BSA mixture was added to paraffin oil containing 
Span 80 and microspheres were synthesized as described previously. 
2.2.5.2. Incubation method - loading BSA by immersion 
In addition to the above incorporation method, an alternative protein encapsulation 
method is the incubation method [105, 130]. Specifically, the freeze-dried blank microspheres 
were suspended in a solution containing 0.15% (wt/vol) of sodium chloride (NaCl) and known 
amounts of BSA. The mixture was then gently agitated for 2 hours at room temperature to allow 
uptake of BSA into microspheres, after which the microspheres were soaked in 1 M of CaCl2 for 
10 minutes. The microspheres were centrifuged at 1000 rpm for 10 minutes, and then washed 
twice with water. For every 10 mg of dried microspheres, 1 mL of 0.1 mg/mL or 1 mg/mL of 
BSA solution was used. 
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2.2.6. Determination of encapsulation efficiency 
Microspheres were weighed by a scale, and then suspended in phosphate buffered saline 
(PBS). The samples were kept in PBS and shaken for 24 hours to promote release of all loaded 
protein. The samples were centrifuged at 4000 rpm for 15 minutes, and the protein content in the 
supernatant was analyzed using a Bradford protein assay with spectrophotometry at a wavelength 
of 595 nm. The blank microspheres were used as a control group. The encapsulation efficiency 
and loading efficiency were determined from the average of three batches of samples, and was 
calculated from the following equations, respectively. 
Encapsulation efficiency %   = Mass of loaded proteinMass of added  protein  ×100                                         (Equation 2.1)  
Loading capacity %   = Mass of loaded protein
Mass of microspheres
 ×100                                                     (Equation 2.2)  
2.2.7. Studies of protein release from microspheres in vitro 
For coated and uncoated BSA-loaded microspheres prepared under varying conditions as 
listed in Table 2.1, 20 mg of dried microspheres were suspended in 1 mL of 10 mM PBS (pH7.4) 
in a microcentrifuge tube. The samples were incubated at 37 °C while shaking at 100 rpm. At 
predetermined time intervals, the samples were centrifuged at 5000 rpm for 10 minutes, and the 
whole 1 mL of release medium was collected. The BSA concentration in the supernatant 
collected was determined using a Bradford protein assay. The pellets of microspheres were 
resuspended in 1 mL of fresh PBS and the procedure was repeated until the end of the 
experiment. 
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Table 2.1. Conditions used to prepare alginate and BSA-loaded alginate microspheres. 
Abbreviations CaCl2 concentration BSA loading method Chitosan coating 
1%-Alg-Ch 
1% 
No BSA 
yes 
1%-Alg-Un no 
1%-Incorp-Ch 
Incorporation method 
yes 
1%-Incorp-Un no 
1%-Incoub-Ch 
Incubation method 
yes 
1%-Incub-Un no 
10%-Alg-Ch 
10% 
No BSA 
yes 
10%-Alg-Un no 
10%-Incorp-Ch 
Incorporation method 
yes 
10%-Incorp-Un no 
10%-Incub-Ch 
Incubation method 
yes 
10%-Incub-Un no 
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2.2.8. Preparation of microspheres embedded within alginate cylinder scaffolds 
Accurately weighed dry microspheres were mixed with 2% alginate solution to obtain a 
weight-to-volume percentage of 5%. The microsphere-alginate mixture was immediately injected 
into a Silastic tubing (Dow Corning, Midland, MI) with an inner diameter of 1.47 mm. The 
tubing was immersed in 1 M of CaCl2 overnight at 4 °C, and a cylindrical-shaped alginate 
scaffold was formed, which was then pushed out the tubing and soaked in 1 M of CaCl2 at 4 °C 
for 2 hours before use. 
2.2.9. Studies of protein release from scaffolds in vitro 
The cylindrical microsphere-alginate scaffolds were cut into pieces with a length of 1 cm. 
Alginate cylinders incorporated with BSA-loaded-microsphere, as well as a control sample made 
with blank microspheres, were placed into 24-well cell culture plates. Each alginate cylinder was 
placed in one well, and 1 mL of DMEM was added as release medium. The plates were then 
agitated in a shaker at 100 rpm for 48 hours at 37 °C. At scheduled time intervals, 1 mL of 
release medium was collected and analyzed for BSA concentration. Release medium was 
replaced with 1 mL of fresh DMEM. All BSA concentration analyses were done in triplicate. 
2.3. Results and discussion 
2.3.1. Alginate microspheres 
Figure 2.1, 2.2, and 2.3 are optical and SEM micrographs of alginate microspheres, 
chitosan coated alginate microspheres, and BSA-loaded microspheres. The images show that the 
paraffin oil/Span 80 emulsion system is able to produce alginate microspheres with good 
spherical shape and a smooth surface. From Figure 2.2 and 2.3, it is observed that the chitosan 
coated alginate microspheres have fuzzier surfaces and there are more conjunctions of spheres. 
The formation of a thin chitosan membrane surrounding the alginate microspheres contributes to 
the surface characteristics. Using the emulsion technique, alginate microspheres with or without 
BSA have been successfully prepared under the conditions listed in Table 2.1.  
The particle size analyses showed that the concentration of CaCl2 solution, and the 
chitosan coating have effects on the diameters of alginate microspheres (Table 2.2). The 
measurements of diameters revealed that particle size increases when the amount of calcium 
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crosslinker used decreases, and that the chitosan coating increases the diameters of microspheres 
as expected. Figure 2.3 shows the size distribution of alginate microspheres prepared with 10% 
CaCl2. Increasing CaCl2 concentration during the emulsion process reduces the diameters and 
narrows the size distribution of alginate microspheres. The majority of alginate microspheres are 
approximately 10 µm in diameter (Figure 2.4). The mean diameters of microspheres were 
reduced from 20.5±9.1 µm to 6.5±2.8 µm when the CaCl2 concentration used in the gelation 
process was increased. The decrease in microsphere size and size distribution is mainly caused 
by the syneresis of alginate hydrogels in high calcium concentration [87]. The shrinkage of 
alginate microspheres volume occurs due to contractions of alginate polymers upon crosslinking 
reaction with calcium ions. The changes in the mean diameters revealed that the syneresis effect 
increases as the calcium concentration increases. 
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Figure 2.1. Optical photomicrograph of alginate microspheres prepared with (A) 1% CaCl2 and 
(B) 10% CaCl2, both of which have the same scale. 
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Figure 2.2. SEM micrographs of alginate microspheres prepared with 
1% CaCl2. (A) alginate microspheres, (B) chitosan coated alginate 
microspheres, (C) BSA loaded-alginate microspheres by incorporation 
methods, and (D) BSA loaded-alginate microspheres by incubation 
methods. 
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Figure 2.3. SEM micrographs of alginate microspheres prepared with 
10% CaCl2. (A) alginate microspheres, (B) chitosan coated alginate 
microspheres, (C) BSA loaded-alginate microspheres by incorporation 
methods, and (D) BSA loaded-alginate microspheres by incubation 
methods. 
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Table 2.2. Diameters of microspheres made under different conditions. 
CaCl2 Concentration used 
(weight/volume) Types of microspheres 
Mean Diameters 
(µm) 
1% 
Alginate microspheres 20.5 ± 9.1 
Alginate microspheres coated with 
chitosan 21.7 ± 9.3 
Alginate microspheres BSA loaded 
by incorporation method 23.1 ± 9.6 
Chitosan coated alginate 
microspheres BSA loaded by 
incorporation method 
24.8 ± 10.2 
Alginate microspheres BSA loaded 
by incubation method 22.4 ± 10.7 
Chitosan coated alginate 
microspheres BSA loaded by 
incubation method 
23.3 ± 11.5 
10% 
Alginate microspheres 6.2 ± 2.8 
Alginate microspheres coated with 
chitosan 7.6 ± 3.3 
Alginate microspheres BSA loaded 
by incorporation method 8.0 ± 3.6 
Chitosan coated alginate 
microspheres BSA loaded by 
incorporation method 
10.1 ± 5.0 
Alginate microspheres BSA loaded 
by incubation method 8.2 ± 4.3 
Chitosan coated alginate 
microspheres BSA loaded by 
incubation method 
9.0 ± 4.8 
All measurements were made using freeze-dried microspheres suspended in water. Data are 
shown in mean ± S.D. (n = 200). 
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Figure 2.4. Size distribution of alginate microspheres made with 10% 
CaCl2. 
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2.3.2. Encapsulation efficiency of different loading methods 
The loading efficiency and encapsulation efficiency of BSA loaded alginate microspheres 
are calculated and reported in Table 2.3. The theoretical maximum loading efficiency is 1%, 
since the weight ratio of alginate and BSA used is 100 to 1. It was found that BSA loading 
efficiency is well below the theoretical maximum in all cases. However, the incorporation 
methods produced much better encapsulation efficiency than the incubation method. This could 
be explained by the electrostatic charges on BSA and alginate molecules at neutral pH. At 
neutral pH, the repulsive force between the negatively charged BSA and alginate contribute to 
the reduction in the encapsulation efficiency of the incubation method. The modest encapsulation 
efficiency of incorporation method could be affected by protein-alginate interaction during the 
emulsification process and by protein diffusion during washing steps after the microspheres have 
formed. The BSA molecule is known to have a small hydrodynamic volume and molecular 
weight [131], which increase the possibility of diffusing out of microspheres during the 
preparation processes. However, in the case the incubation methods, the small size of BSA does 
not offer significant advantages. The low encapsulation efficiencies of microspheres using 
incubation methods suggest that the negative charges of BSA are more influential than size in 
term of diffusive properties in alginate gels. 
 
 
Table 2.3. Calculated loading efficiency and encapsulation efficiency of alginate microspheres. 
CaCl2 concentration BSA loading method 
Loading efficiency 
(% w/w) 
Encapsulation 
efficiency (% w/w) 
1% Incorporation method 0.44 44 Incubation method 0.04 4.5 
10% Incorporation method 0.36 39 Incubation method 0.08 7.8 
The shown loading and encapsulation efficiency are the averages of three percentages and are 
calculated using Equation 2.1 and 2.2, respectively. 
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2.3.3. Effects of preparation parameters 
The in vitro BSA release from alginate microspheres prepared under different conditions 
was investigated under isothermal conditions. The influence of CaCl2 concentration used during 
emulsion processes, the protein loading methods, and the chitosan coating on alginate 
microspheres on BSA release behaviours was studied in PBS at 37 °C.  
Figure 2.5 shows that BSA loaded using incorporation methods was released more slowly 
than when loaded using incubation methods, despite the amount of crosslinking regents used. In 
all of the protein release experiments, protein loaded with incubation methods was released faster 
than incorporation methods during all stages of release. One possible cause is that, during 
incubation time, more proteins were deposited on the microsphere surface rather than diffused 
into microspheres. Since the protein release kinetics is affected by both protein diffusion kinetics 
and degradation of microspheres themselves, the proteins adhered onto the microsphere surface 
contribute largely to the faster release.  
The influence of degradation of microspheres on release profiles was studied through 
altering the crosslinking degree of alginate microspheres by using different amount of CaCl2; 
presumably, more calcium cations would provide a higher degree of crosslinking. For protein 
loaded with incorporation methods (Figure 2.6), increased calcium cations slowed down the 
protein release over the time course of the experiment. However, for protein loaded with 
incubation methods, superimposed release profiles were observed for microspheres prepared 
with 1% and 10% CaCl2. This observation also could be explained by proteins adhering onto the 
microsphere surface during incubation loading. Therefore, the degree of crosslinking of 
microspheres did not play an important role in protein release rate from incubation-loaded 
microspheres, since a large portion of the protein was simply dissociated from the microsphere 
surface instead of diffusing from inside. For microspheres prepared using the incorporation 
method, higher concentration of calcium cations delayed the protein release slightly during the 
first 5 hours of releasing time course, but after the initial bursting period, incorporation-loaded 
microspheres made with low and high concentration of calcium cations showed similar release 
profiles. 
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The dissociation and diffusion of proteins from the surface and from the inside of alginate 
microspheres was delayed by coating alginate microspheres with diluted chitosan solution in all 
tested cases. A better control of BSA release was observed in chitosan coated microspheres 
(Figure 2.5 and 2.6). Not surprisingly, chitosan coated alginate microspheres made with either 1% 
or 10% CaCl2 showed slower and more sustained release of proteins comparing to uncoated ones, 
from which proteins were completely released in the first 5 hours. In the case of chitosan coated 
microspheres, protein release was still detectable at 48 hours. It has been established that 
chitosan coating stabilizes alginate microspheres and lengthens the protein release [71, 110, 112, 
132]. The positively charged amino groups of chitosan form ionic bonds with negatively charged 
carboxyl groups of alginate, forming a thin layer of chitosan membrane on alginate microspheres. 
The chitosan layers protect alginate microspheres from osmotic pressure and diffusion of ions, 
and thus reduce the initial burst release and rate of decrosslinking of microspheres. 
The initial burst effect of alginate microspheres is inevitable in all cases. However, higher 
degree of crosslinking of alginate polymer can slow down the burst effect to an extent. Also, the 
complete release of proteins could be delayed from 5 hours to 50 hours by coating the alginate 
microspheres. Alginate microspheres loaded with incubation methods presented faster and 
shorter release profiles in comparison to ones loaded with incorporation methods. 
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Figure 2.5. The effect of protein loading methods. In each panel, the accumulated BSA release 
of alginate microspheres prepared with either incorporation or incubation method in PBS are 
represented as mean ± S.D. (n = 3). Chitosan coated alginate microspheres prepared with either 
1% CaCl2 (A) or 10% CaCl2 (C). Uncoated alginate microspheres prepared with either 1% 
CaCl2 (B) or 10% CaCl2 (D). 
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Figure 2.6. The effect of CaCl2 concentration. In each panel, the accumulated BSA release in 
PBS of alginate microspheres prepared with either 1% or 10% CaCl2 are represented as mean ± 
S.D. (n = 3). Chitosan coated alginate microspheres loaded with incorporation method (A) or 
incubation method (C). Uncoated alginate microspheres loaded with incorporation method (B) or 
incubation method (D). 
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Figure 2.7. Release profiles of BSA from microsphere-incorporated alginate scaffolds in 
DMEM at 37 °C. Alginate scaffolds prepared using 10%-microspheres with: coating and 
incorporation method (●), uncoated and incorporation method (○), coating and incubation 
method (■), and uncoated and incubation method (♦). Values represent means ± S.D. (n = 
3). 
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2.3.4. Studies of microsphere-containing alginate scaffolds in vitro 
Alginate cylindrical scaffolds containing incorporated microspheres were moulded in 
silicone tubing overnight, and further gelled in CaCl2 for 2 hours after solid gels were obtained. 
The external gelation process was purely dependent on the diffusion of calcium ions into alginate 
hydrogels. Shrinkage in hydrogel volume was observed; thus, the diameters of gelled alginate 
scaffolds were approximately 80% of that of the inside diameter of the silicone tubing. The BSA 
release behaviour from these scaffolds was studied in DMEM at 37 °C. The initial burst release 
was reduced and the release was prolonged in all microsphere-embedded scaffolds (Figure 2.7). 
The release curves of scaffolds follow a trend similar to alginate microspheres, but the rate of 
BSA release was decreased. As expected, BSA released from alginate scaffolds containing 
microspheres made using the incorporation protein loading method is slower than from the ones 
containing microspheres made with incubation methods. For microspheres prepared with each 
loading method, chitosan coating results in slower release after the initial burst stage. Although 
the time interval of initial burst release was not retarded, the percentages of total loaded BSA 
was reduced during that earlier period. This phenomenon could be due to the fact that alginate 
hydrogels surrounding the microspheres provided a barrier for fast ion diffusion. However, the 
dissolution and swelling rate of alginate hydrogels are expected to be rapid in medium containing 
monovalent cations that can substitute for calcium [133]. As a result, the fast dissolution of 
alginate in DMEM eventually leads to fast diffusion of ions into microspheres. On the other hand, 
the freeze-dried microspheres have a larger swelling rate than wet ones [134]. The quick 
expansion in microsphere volume could change the bulk network of alginate hydrogel, which in 
turn could accelerate the diffusion of BSA and other ions. The decrosslinking and dissolution 
process of alginate microspheres and hydrogels impose effects on each other, and thus influence 
the BSA release kinetics together. It can be concluded that BSA release was affected by the 
combined physicochemical properties of alginate microspheres and hydrogels. 
  
38 
 
Chapter 3. Alginate microspheres for release of IgG 
3.1. Introduction  
As described in chapter 2, the alginate microspheres prepared using the emulsion/external 
gelation method have large diameters and wide size distribution. Many researchers have 
attempted to produce small and homogenous alginate microspheres by optimizing preparation 
parameters in the emulsion process. It has been reported that the diameters of alginate 
microspheres ranged from 500 to 800 µm in one earlier study [97], and were reduced to 8 µm 
[66] and 5 µm [56] in other studies by improving preparation formulations. Also, the 
encapsulation efficiency and release kinetics of proteins were found to be significantly 
influenced by the molecular weights and isoelectric points of proteins [71, 135]. Release studies 
of different proteins have reported that the protein chemical properties and their interaction with 
alginate polymers are related to their release profiles. Proteins with high pI, such as the growth 
factor bFGF, have been shown to have higher affinity with alginate hydrogels [118]. The 
angiogenic growth factor VEGF, which has a high molecular weight and high pI value, was 
encapsulated into alginate beads by extruding alginate-VEGF solution into CaCl2 solution, 
resulting in a high encapsulation efficiency and sustained release of VEGF [136]. A recent in 
vitro study showed that lysozyme and chymotrypsin, both with molecular weights lower than 25 
kDa and high pI values, had lengthy and extended release from alginate beads produced by 
extrusion methods, as compared with release profiles of BSA [105]. However, the release 
behaviours of IgG, which is a high pI protein with large molecular weight, from alginate 
microspheres prepared with emulsion/external gelation methods have not been well studied. It 
therefore seems worthwhile to investigate microencapsulation techniques of a variety of proteins 
for accomplishing prolonged protein release and tailoring protein release to fit different 
conditions. 
Local and sustained protein release has been achieved by using microsphere-embedded 
polymeric scaffolds in vitro [118, 119]. Alginate microspheres have been demonstrated as 
potential delivery vehicles for BSA, and we have shown in chapter 2 that alginate microsphere 
incorporating scaffolds extend the protein release rate. It is of interest whether preparation 
parameters for alginate microspheres could be further improved, and whether the typical burst 
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effect of alginate microspheres could be reduced effectively and proteins could be released in a 
controllable manner by using microsphere incorporated scaffolds to release a different protein. 
The previous study shows the necessity of further investigation of parameters of alginate 
microsphere preparation and release kinetics of different proteins. In the present study, the 
encapsulation of immunoglobulin G (IgG), a protein with high molecular weight and high pI, in 
calcium alginate microspheres coated with chitosan was investigated. The IgG-loaded alginate 
microspheres were prepared using a smaller emulsion volume, in order to decrease the amount of 
protein needed in microsphere preparation. The physical properties, encapsulation efficiency, 
and in vitro release kinetics of IgG encapsulating alginate microspheres were analyzed. Also, 
microsphere-incorporated alginate cylindrical hydrogels were fabricated using alginate 
microspheres with or without chitosan coating. The alginate cylindrical hydrogels were prepared 
by extruding a microsphere-alginate mixture into a high concentration of CaCl2, which provides 
the benefit of fast gelation of alginate exposed to calcium ions. The release of IgG from this 
alginate hydrogel and the influence of chitosan coating and hydrogel composition were examined 
in vitro. 
3.2. Materials and methods 
3.2.1. Materials 
All materials used were obtained from the same source described in Chapter 2. 
Immunoglobulin G (IgG) from rabbit serum was obtained from Sigma (Oakville, Canada). 
DyLight 800 antibody labelling kit was purchased from Thermo Fisher Scientific Inc (Nepean, 
Canada).  
3.2.2. Preparation of chitosan coated and uncoated alginate microspheres 
Sodium alginate was dissolved in ultrapure water at room temperature to obtain solution 
of 5% (w/v). Alginate microspheres were prepared using the same emulsion method described in 
chapter 2, but at a smaller scale. Briefly, 50 µL of Span 80 was added into 1 mL of paraffin oil in 
one well of a 24-well plate, and mixed using a mechanical stirrer. Three hundred µL of 5% 
alginate solution was then added dropwise while stirring at 1300 rpm on a mechanical stirrer. 
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After 1 hour of constant mixing, 150 µL of 10% CaCl2 was gradually dropped into the 
homogeneous emulsion solution, and stirred for 1 hour. Pure isopropyl alcohol (300 µL) was 
added to harden the alginate microspheres that were formed. The stirring was continued for 10 
minutes. Microspheres were then collected by centrifuging at 1000 g for 15 minutes, and they 
were washed twice with isopropyl alcohol and once with ultrapure water. Alginate microspheres 
were freeze-dried as described in chapter 2. All batches were prepared in quintuplicate. The 
alginate microspheres were coated with 0.1% chitosan as described in chapter 2 except 
microspheres were used directly after washing without lyophilisation. 
3.2.3. Physical characterization of alginate microspheres 
Lyophilized alginate microspheres were observed with SEM as described in chapter 2. 
3.2.4. Preparation of IgG loaded alginate microspheres 
3.2.4.1. Labeling IgG with near infrared dyes 
The labeling of IgG with DyLight 800 dyes was performed as described in the 
manufacturer’s instructions. The IgG concentration was also determined according to the 
instructions. DyLight 800 labeled IgG was aliquoted and stored in -20 °C until use. 
3.2.4.2. Encapsulating labeled IgG within alginate microspheres 
Protein-loaded alginate microspheres were prepared by the incorporation method 
described in chapter 2. Briefly, 27 µg of labeled IgG in PBS was added to 300 µL of 5% alginate 
solution, and mixed by vortexing. The alginate solution containing labeled IgG was used to form 
a water-in-oil emulsion as described in previous section. 
3.2.5. Release studies of IgG loaded alginate microspheres in vitro 
Approximately 2.5 mg of alginate microspheres was placed into one 1.5 mL 
microcentrifuge tube, and suspended in 1 mL of 20 mM Tris buffered saline (TBS, pH 7.4) with 
2 mM CaCl2. The microsphere suspension was gently shaken horizontally at 100 rpm and 
maintained at 37 °C. Samples were periodically removed from the shaker, and centrifuged at 
1500 g for 15 minutes. An aliquot of 10 µL of the supernatant was removed and transferred to, 
and diluted in a 96-well plate. The same amount of TBS was added to each microtube to replace 
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the removed supernatant, and the microspheres were resuspended for further protein release. The 
96-well plate containing supernatant samples was imaged using a LI-COR Odyssey infrared 
imaging system (Guelph, ON) in the 800 nm channel, and the integrated fluorescence intensities 
for each well were quantified using the LI-COR Odyssey infrared imaging system software. The 
obtained integrated intensities were analyzed using Excel (Microsoft Corp., Redmond, WA) and 
Prism (GraphPad Software, San Diego, CA) software. Known amounts of labeled IgG were 
placed into separated wells of the same 96-well plate to serve as standards during each imaging. 
Plates were protected from light before imaging and scanned as soon as possible after they were 
removed from the shaker. Five samples in each condition were prepared. 
3.2.6. Preparation of microsphere-integrated alginate scaffolds 
Protein-loaded alginate microspheres were used directly after the final washing step to 
reduce the loss of fluorescence intensity of the DyLight 800 label. Known volumes of wet 
microspheres were dispersed into 2% (w/v) alginate solution to get a final microsphere 
concentration of 5% or 7.5% (v/v). The suspensions were immediately injected through Silastic 
tubing with an inner diameter of 1.47 mm into a glass plate containing 1 M CaCl2 solution. The 
tubing was immersed in the CaCl2 solution during the injection process. The microsphere-
alginate suspensions were eluted through the tubing and gelled immediately when they contacted 
the CaCl2 solution. The formed cylindrical shaped gels were allowed to further crosslink in 1 M 
CaCl2 solution for 15 minutes, and were then washed in ultrapure water to remove unreacted 
CaCl2 residue. The completely gelled scaffolds were cut to form cylinders with a length of 1 cm. 
3.2.7. Release studies of IgG in microsphere-integrated alginate scaffolds in vitro 
The cylindrical scaffolds used for release studies were approximately 1.2 mm in diameter 
and 1 cm in length. The scaffolds made with different alginate microspheres were placed into 24-
well plates and immersed in 0.5 mL of 20 mM TBS plus 2 mM CaCl2. Scaffolds made with 
blank alginate microspheres were used as controls. Plates were incubated at 37 °C under gentle 
agitation on a horizontal shaker. At each scheduled time point, 10 µL of the medium was 
collected and replaced with the same volume of fresh medium. The collected samples were 
imaged in 96-well plates using the LI-COR Odyssey infrared imaging system and analyzed as 
described above. All measurements were carried out using five samples from each condition. 
42 
 
3.2.8. Determination of encapsulation efficiency of labeled IgG 
Alginate microspheres loaded with labeled IgG were suspended in 1 mL of 20 mM TBS 
(pH 7.4), and incubated at 37 °C for 3 days with gentle agitation to promote complete protein 
release. Microspheres were separated from the incubation medium by centrifugation at 1500 g 
for 15 minutes. The supernatants that were collected were imaged by a LI-COR Odyssey infrared 
imaging system (Guelph, ON), and the amount of labeled IgG was analyzed as described in 
section 3.2.5. The fluorescent intensities of alginate microspheres after 3-day incubation were 
also observed by light microscopy to ensure complete release of labeled IgG from microspheres. 
The encapsulation efficiency (EE) was calculated from equation 3.1, and three batches were used 
for calculations. 
EE% = Mass of loaded IgG
Mass of added IgG
 ×100                                                                                       (Equation 3.1) 
3.3. Results and discussion 
3.3.1. Properties of alginate microsphere 
Alginate microspheres were successfully prepared using the small volume emulsion 
system with and without labeled IgG. The scanning electron micrographs show spherical shaped 
microsphere with approximately diameter of 1 to 3 µm in a relative narrow size distribution 
(Figure 3.1 and 3.2). The SEM images demonstrate that the emulsion process and formulation 
parameters that we used resulted in alginate microspheres with good morphological 
characteristics and small size. Alginate microspheres prepared with and without incorporation of 
labeled IgG show no distinguishable differences in shape and surface morphology.  
The formation of small and uniform alginate microspheres using this emulsion system 
could be affected by several process parameters, such as polymer concentration, polymer-to-oil 
ratio, emulsifier concentration, stirring speed, and volume of processing medium. The surfactant 
concentration, which is 5% (w/w), was kept constant through the experiments. It has been found 
that higher emulsifier concentration in water-in-oil emulsion can reduce the diameters of the 
resultant microspheres [137]. Comparing the microsphere preparation formulation in section 2.2 
and 3.2, the processing medium, and the stirring speed were altered. The processing medium was 
reduced from 50 mL to 1 mL, and the container used was changed from a beaker to a 24-well 
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plate, which result in smaller and more uniform microspheres. However, the volume ratio 
between alginate solution and paraffin oil and the concentration of emulsifier remained 
unchanged. The lowest effective Span concentration that can form a stable emulsion is 2%. The 
Span 80 concentration used, 5%, was high enough to decrease the surface tension between the 
aqueous droplets and surrounding oil medium, and form stable alginate droplets in paraffin oil 
during the emulsion process. Therefore, the polymer-to-oil ratio and emulsifier concentration are 
likely not the major contributors to the size and uniformity of microspheres. However, the 
geometry of the container, the stir bar size, and the sample volume should be taken into 
consideration for the changes in size and uniformity of microspheres. The reduction in the 
volume of processing medium and container could increase the effectiveness of mechanical 
stirring of stir bars, which in turn can produce smaller and more uniform alginate droplets during 
the emulsion process. Also, the increase of stirring speed from 1200 to 1300 rpm could also 
contribute to the more effective dispersion of alginate solution in the paraffin oil. A higher 
stirring speed can provide more energy for dispersion, which reduces the size and increases 
uniformity of microspheres [138]. Formation of spherical, small, and uniform aqueous droplets 
in the oil phase is a key step for preparing microspheres using the emulsion technique. 
Isopropyl alcohol is commonly used as a dehydrating agent after emulsification process, 
and as washing medium in alginate microsphere preparation [120, 139]. It has been found that 
isopropyl alcohol hardened and washed alginate microspheres generally have smooth surfaces, 
spherical shape, and reduced aggregation effects.  
We used the small scale microsphere preparation method and the incorporation method 
for protein loading to prepare IgG incorporating alginate microspheres.  Table 3.1 shows that this 
process resulted in a high encapsulation efficiency. Due to the insolubility of protein in isopropyl 
alcohol, protein loss during washing cycles could be minimized, which in turn increases the 
protein encapsulation efficiency. The results obtained show that using isopropyl alcohol to 
harden and wash alginate microspheres in which encapsulated protein is insoluble is suitable. 
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Table 3.1. Alginate microspheres prepared and IgG encapsulation efficiency. 
Condition 
abbreviations IgG encapsulation 
Encapsulation 
efficiency (%) Coating 
Alg-Un No N/A No coating Alg-Ch 0.1% chitosan 
IgG-Un Yes 89.4 ± 6.4 No coating IgG-Ch 0.1% chitosan 
The EE percentages are shown in mean ± S.D. (n = 5). 
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Figure 3.1. Optical photomicrograph of alginate 
microspheres prepared with 10% CaCl2 in small 
volume. 
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Figure 3.2. SEM images of (A) alginate microspheres and (B) IgG loaded alginate microspheres. 
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3.3.2. Release kinetics of IgG from alginate microspheres in vitro 
In vitro release of labeled IgG from alginate microspheres with or without chitosan 
coating was investigated. The releasing medium contained 2 mM CaCl2 in order to study the 
dissolution, disassociation, and degradation of alginate microspheres under physiological 
conditions. At predetermined time intervals, only 1% of total releasing medium was removed for 
analysis, in order to not affect the accumulated concentration of IgG protein in the releasing 
medium. The changes in the concentration of IgG protein in the surrounding medium produce 
concentration gradient between the IgG encapsulated inside microspheres and in the surrounding 
medium, which artificially promotes protein release into a medium with lower IgG concentration. 
To better illustrate the accumulated IgG release, no concentration gradient was induced in the 
release studies.  
The accumulated IgG release was measured in TBS (pH 7.4) with the presence of 2 mM 
CaCl2 and the release profiles are shown in Figure 3.3. The prolonged and sustained release 
profiles of IgG from chitosan coated and uncoated alginate microspheres show that IgG proteins 
were successfully encapsulated within the interior of the alginate microspheres. The release of 
IgG from alginate microspheres was rapid during the first 2 to 5 hours with or without chitosan 
coating, which is presumably caused by the fast release of IgG adsorbed onto microsphere 
surface, and the initial burst of alginate microspheres once they were introduced into aqueous 
solution with neutral pH. However, the IgG was completely released from alginate microspheres 
within 160 hours, where only 50% of IgG was released from chitosan coated alginate 
microspheres during that time. Also, a more noticeable slowed release is observed in the chitosan 
coated microspheres after the initial burst effect. Therefore, the chitosan coating could 
effectively reduce the initial burst effect, and slow down the overall releasing time. 
The release and diffusion of encapsulated IgG could be influenced by many factors, such 
as the size of protein, the pore size of the microspheres, the dissolution of alginate molecules, the 
breakdown of alginate polymer, and the degradation rate of alginate. The release profile of 
uncoated alginate microspheres is relatively smooth, potentially indicating that swelling and 
dissolution of small and uniform microspheres prepared with high alginate concentration are 
slow in TBS with added calcium ions. The release curves done in a different buffer solution, PBS, 
showed a greater swelling and a more obvious burst effect comparing to release curves done in 
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TBS. This phenomenon could be caused by the increased extraction (and precipitation) of 
calcium ions in microspheres by phosphate ions in PBS. On the contrary, Tris is an organic 
compound which does not form insoluble precipitates with calcium ions.  
The release of IgG was slowed down after the chitosan coating process, which indicates 
that the chitosan coating was successful and the chitosan membrane outside the microspheres 
protects them from the surrounding aqueous medium. The chitosan membrane is formed due to 
the electrostatic interaction between the carboxyl groups of alginate and the amine groups of 
chitosan. The chitosan coating process was done under an acidic environment (pH 5) where the 
amine groups of chitosan are positively charged and carboxyl groups of alginate are negatively 
charged. When the chitosan coated alginate microspheres were suspended in buffer at pH 7.4, the 
chitosan molecules are deprotonated, and thus, the charge density of chitosan molecules was 
reduced. Therefore, the electrostatic interaction between amine groups and carboxyl groups was 
weakened, which leads to dissolution of chitosan molecules from the microsphere surface. 
However, the release profiles reveal that the disassociation of microspheres and their chitosan 
membrane is slow enough so that IgG release is still retarded. Also, the prolonged IgG release 
from chitosan coated microspheres could be caused by a diminished swelling effect of 
microsphere core, which is the major cause of the initial burst effect.  
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Figure 3.3. Percent cumulative release of IgG from alginate microspheres (•), 
and chitosan coated alginate microspheres (○) in TBS at pH7.4 and 37 °C. 
Values represent means ± S.D. (n = 5). 
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3.3.3. Release kinetics of IgG from microsphere-containing alginate scaffolds in vitro 
Alginate solutions containing suspended microspheres extruded into 1 M CaCl2 solution 
through silicone tubing solidified instantly and formed opalescent gels upon contact with the 
CaCl2 solution. While these gels were further crosslinked in CaCl2 solution, shrinkage of gels 
was observed. It has been found that penetration of calcium ions into the interior of alginate 
hydrogels induces water diffusion toward the outside of the gels [140]. The crosslinking of the 
exterior of alginate gels is extremely fast, but the gelation of the interior is highly dependent on 
the diffusion rate of calcium ions, and therefore the size or the thickness of hydrogels [141]. The 
rapidly crosslinked outer layer of alginate gels essentially forms a membrane between exterior 
calcium ions and interior carboxyl group of alginate molecules, thus creating a barrier for further 
diffusion of calcium ions into the interior of gels. The limitation of calcium ions diffusion slows 
down the crosslinking reactions inside the hydrogels, meaning a complete crosslinking process 
could take up to one day depending on the size of gels [140]. However, a significant amount of 
encapsulated protein in alginate microspheres diffuse out when they are washed with 50 mM 
CaCl2 [93]; thus a solution with high concentration of calcium ions does not prevent the leakage 
of protein. As a result, exchange of calcium ions and water molecules during long term 
crosslinking could induce diffusion of encapsulated protein out of alginate microspheres, which 
could leak out of alginate gels. In fact, it has been proven that a 10 to 20 minute gelation time 
could produce a small stable alginate hydrogel [94, 141]. Therefore, the total gelation time in 
CaCl2 solution used was 20 minutes. It was assumed that a high concentration of CaCl2 could 
accelerate the crosslinking process, although there could be a threshold to the CaCl2 
concentration required. The CaCl2 concentration chosen, 1 M, could be the main cause for the 
contraction of the alginate cylinders due to the osmotic effect. Indeed, the diameters of alginate 
cylinders obtained were approximate 75-80% of the diameter of silicone tubing, which further 
shows that short term gelation can be effective. The results show that alginate cylinder scaffolds 
maintained their cylindrical shape over the 2-week study. Although they appeared to be more 
translucent and more fragile over time, possibly due to swelling of hydrogels and breakage of 
microspheres, alginate hydrogels prepared are quite stable at the given experimental conditions. 
Alginate microspheres encapsulating IgG were incorporated in a cylinder-shaped alginate 
scaffold at different densities. Alginate gel scaffold mixed with 5% or 7.5% of either non-coated 
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and chitosan coated alginate microspheres were evaluated for their protein release kinetics 
(Figure 3.4). For all of the incorporated scaffolds prepared using 5% alginate microspheres (IgG-
Un-5%), 7.5% alginate microspheres (IgG-Un-7.5%), 5% chitosan coated alginate microspheres 
(IgG-Ch-5%), and 7.5% chitosan coated alginate microspheres (IgG-Ch-7.5%), the rates of 
protein release were decreased comparing to IgG released form microspheres alone. The results 
are reported as percentages of IgG released compared to the total IgG encapsulated in 
microspheres for each centimeter of scaffolds. By the last day of release study, cumulative 
release of IgG from scaffolds containing IgG-Un-7.5% microspheres was 34.10±0.83% of loaded 
IgG, from scaffolds containing IgG-Un-5% was 27.08±0.68% of IgG, from scaffolds containing 
IgG-Ch-7.5% was 18.68±0.52% of IgG, and from scaffolds containing IgG-Ch-5% was 
14.03±0.68% of IgG. The release profiles of all microsphere-incorporated gel scaffolds reveal 
that IgG release was retarded and elongated compared to microspheres alone, and the initial burst 
effects of microspheres were diminished possibly due to the protection from alginate hydrogel.  
The amount of microspheres embedded in alginate gel scaffolds affects the IgG release 
kinetics. As expected, more IgG is released from scaffolds embedded with more IgG loaded 
microspheres. Comparing cumulative IgG release between scaffolds with 5% and 7.5% of 
microspheres, approximately 1.5 times more IgG released from scaffolds with 7.5% 
microspheres than with 5% microspheres. This result also suggests that differential degradation 
and dissolution of alginate hydrogels with changing microsphere density did not impact the 
protein release kinetics significantly over the course of the release study. It is possibly due to the 
fact that calcium crosslinked alginate hydrogels are stable in neutral buffer with added calcium 
ions. Slower release of IgG is observed in scaffolds made with chitosan coated microspheres 
than uncoated microspheres. In all cases, IgG was released over extended time period from 
embedded hydrogels comparing to microspheres. 
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Figure 3.4. Percent cumulative release of IgG from one centimeter microspheres-incorporated 
scaffolds in TBS at pH7.4 and 37 °C. Alginate scaffolds prepared with different IgG-loaded 
microspheres: 5% alginate microspheres (□), 7.5% alginate microspheres (■), 5% chitosan 
coated alginate microspheres (○), and 7.5% chitosan coated alginate microspheres (●).Values 
represent means ± S.D. (n = 5). 
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Chapter 4. General discussion     
4.1. Preparation of alginate microspheres 
Alginate microspheres can be prepared by a two-step process: emulsification and external 
ionic gelation [66, 120, 121, 142]. In a general microsphere preparation process, the alginate 
solution was added slowly into an oil phase containing proper surfactants and stirred to form 
emulsion droplets, which is followed by gelation of formed droplets induced by addition of 
CaCl2 solution. The solidified alginate microspheres are then hardened and washed in 
dehydration agents. It has been found that formation of alginate microspheres is affected by the 
formulation parameters used in the emulsification process. Various formulation and preparation 
parameters, such as surfactant properties [143], stirring speeds [93], stirring time, type of oil 
[144], polymer concentration [66, 121], and polymer-to-oil volume ratio, have been reported to 
play an important role in the formation of an emulsion. Also, the size and shape of alginate 
microspheres formed are affected by the volume and concentration of calcium chloride used in 
the ionic gelation step [121]. Generally, all alginate microspheres obtained from the current 
study have a spherical shape and smooth surface. However, alginate microspheres prepared with 
different formulation parameters showed variations in morphology and protein release kinetics. 
The size and size distribution of the microspheres vary with the changes in the 
emulsification/gelation formulation, and protein-loaded microspheres exhibit different release 
profiles due to their distinct physicochemical properties. 
4.2. Effect of emulsifier concentration 
The use of surfactants is critical for dispersion of two immiscible liquids to a stable 
emulsion. Span 80, an oil soluble surfactant, has been used to produce stable aqueous droplets in 
paraffin oil due to its ability to reduce the high interfacial tension when its concentration is equal 
to or above its critical micelle concentration (CMC) [52, 54]. Although aqueous phase could be 
dispersed as small globules in the oil phase with low Span 80 concentration, the stability of these 
globules is low causing distortion and coalescence [145]. Hence, the surfactant concentration that 
is used is generally equal or greater to its CMC.  
The CMC of Span 80 has been established to be 0.5% (w/w) at a water-paraffin oil 
interface, and a concentration greater than the CMC can effectively produce water-in-oil 
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microemulsions [146]. It also has been reported that high concentration of Span 80 could 
produce highly stable emulsions in paraffin oil at short stirring time and hinder the coalescence 
of droplets, which is a crucial factor for formation of spherical and uniform aqueous droplets. In 
fact, sorbitan monoleate or Span 80 was found to produce smaller microspheres, since its straight 
chain fatty acid can effectively adsorb onto the alginate globules and pack them closely [147].  
In addition, the properties of Span 80, for example, hydrophile-lipophile balance (HLB) 
has been found to influence the size and shape of microspheres obtained using emulsification 
methods [143, 145]. The influences of different of surfactants have been investigated, and the 
results demonstrated that non-ionic surfactants with lower HLB, such as Span 80, have a higher 
ability to produce smaller alginate microspheres [66, 143]. Previous studies also have shown that 
emulsifiers with one single long straight chain fatty acid and lower HLB produce smaller 
macromolecule-loaded microspheres with higher encapsulation efficiencies and slower release 
rates [120, 143, 145].  
The paraffin oil/Span 80 emulsion system was first introduced for preparing covalently 
crosslinked chitosan microspheres [116]. Chitosan microspheres with diameters ranging from 
274 to 450 µm were prepared in 100 mL of paraffin oil containing 0.5% Span 80 stirring at 700 
rpm. When the emulsion mixture of chitosan solution and paraffin oil containing 1% Span 80 
was stirred at 1000-3000 rpm, the diameters of chitosan microspheres were reduced to about 10-
14 µm [117]. A recent study used dispersion of 150 mL of chitosan solution-paraffin oil with 2% 
Span 80 to obtain microspheres with mean diameters of 20-31 µm depending on the crosslinker 
concentrations [148]. Alginate microspheres were also prepared with paraffin oil/Span 80 
emulsion system [93]. These alginate microspheres produced in paraffin oil with 1% Span 80 
stirred at 400 rpm, but gelled internally, have diameters of 26.0±9.7 µm.  
An emulsion mixture with a high concentration of Span 80 in paraffin oil was tested for 
its potential to produce externally gelled alginate microspheres. For this reason, 5% of Span 80 
was chosen as the emulsifier in order to sufficiently reduce the interfacial tension between 
alginate phase and paraffin oil phase. Small and stable emulsion globules were produced. As 
expected, the majority of alginate microspheres we prepared using the methods described in 
chapter 2 are smaller than 30 µm (Figure 2.2 and 2.3), and smaller than 3 µm in chapter 3 (Figure 
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3.2). Only small aggregations of microspheres are observed in optical micrographs (Figure 2.1 
and 3.1).  
Alginate microspheres prepared in emulsion system using Span 85, Tween 85, Sodium 
desoxycholate, PVA, or Pluronic F68 in iso-octane have been reported to have diameters ranging 
from 1 to 150 µm, and were observed to have clumps of smaller microspheres [66, 120]. 
Nevertheless, one study stated that an emulsion system made with low concentrations of 
combined Tween 80 and sodium lauryl sulphate in vegetable oil could produce alginate 
microspheres with a mean diameter of 18 µm [149]. The use of a mixture of Tween 80 and 
sodium lauryl sulphate was an attempt to prevent spheres from coalescing during the emulsion 
process, and to reduce the gelation time after the addition of CaCl2 solution. Other studies have 
proven that increasing the Span 80 concentrations could efficiently reduce the probability of 
aqueous globule coalescence [150], and the subsequent diffusion of calcium ions into alginate 
droplets is relatively rapid due to their small size.  
The results obtained in this study confirm that high concentration of Span 80 can produce 
small spherical alginate microspheres with no aggregations. In this present study, 5% of Span 80 
was used in all emulsification process; however, the diameters of alginate microspheres are 
larger than 20 µm when the CaCl2 concentration was lower (Table 2.2), but smaller than 3 µm 
when the CaCl2 concentration was raised and stirring speed was increased (Figure 3.2). 
Therefore, increasing the surfactant concentration well beyond its CMC could facilitate reducing 
the size of emulsion droplets if other influential factors of emulsion formation remain unchanged. 
Also, the size and shape of micelles not only rely on the surfactant concentration, but also on the 
surfactant molecular architecture and the physical interaction between the surfactant and the two 
phases. The experimental results of this research revealed that the Span 80 concentration used 
maintains the spheroidal shape of the microspheres, but displays limited effects on microsphere 
size and size distribution. 
4.3. Calcium chloride concentration 
After the micelles have been formed in an emulsion mixture, ionic crosslinking of 
alginate using internal or external calcium sources is required to stabilize the spheroidal shape 
and to form solid microspheres. The method of using calcium carbonate as an internal gelation 
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source requires activation of the crosslinking process by glacial acetic acid, which causes a 
sudden pH reduction to 5 in the emulsion mixture [93, 151]. Stability or resistance of 
encapsulated materials to the quick change of pH are needed for using this internal gelation 
method in the emulsification process.  
Internal gelation methods produce homogeneous but more porous alginate gels, since the 
calcium ions are uniformly distributed in alginate solution initially, and then the proton-induced 
gelation occurs at the gel surface moving into the inner core [151]. Using calcium ions as the 
external source is an alternative way for alginate crosslinking because it creates a mild condition 
for ionic interaction at neutral pH. External gelation methods utilize the self-assemble abilities of 
two phases between surfactants; thus when the aqueous CaCl2 solution is introduced into 
emulsion system, the system is disrupted to allow the distribution of calcium ions into aqueous 
alginate micelles already formed and then return to the system to a new equilibrium while 
stirring. In the external gelation methods, the initial contact points of alginate molecules and 
calcium ions are at the sphere surface and the gelation process depends on the movement of free 
calcium ions and alginate molecules. As a consequence, a less permeable and smooth surface is 
formed initially, which immobilizes alginate molecules and encapsulants near the gel surface but 
reduces diffusion of calcium ions into the sphere core. However, external gelation methods 
produce spheres with more compact and smooth surfaces than internal gelation methods, which 
provide alginate spheres a higher resistance to ion diffusion [151, 152].  
The low permeability of alginate microspheres is related to the release rate of 
encapsulants; limiting the permeability of crosslinked alginate microspheres is assumed to 
reduce the diffusion rate of encapsulated protein. In fact, the BSA release profiles of alginate 
microspheres prepared with 1% and 10% of CaCl2 solution demonstrate that the release of 
protein depends on the amount of calcium ions used for crosslinking (Figure 2.6). In all cases 
less BSA was released or diffused into medium during the initial stage when the concentration of 
CaCl2 was increased.  
Since the gelation or calcium ions uptake of an alginate gel was found to reach a plateau 
after 30 minutes using different calcium concentrations in external gelation [94, 153, 154], the 
gelation time used in this study is assumed to create microspheres at equilibrium where no 
calcium ion exchange occurs at the end of gelation time. The differences in the BSA release 
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profiles of alginate microspheres are presumably caused by the amount of calcium ions present 
during the gelation process. Higher concentration of calcium cations produces alginate 
microspheres with a highly crosslinked exterior, which in turn decreases the permeability of 
microspheres to further calcium entry. However, Figure 2.6 also indicates that the concentration 
of CaCl2 used for gelation has more effects on the BSA release at the earlier stage of release 
profiles. This suggests that the level of permeability of microspheres is corresponding to the 
diffusion rate of encapsulants at initial release stage.  
This observation could be explained by the fact that the chemical properties of alginate 
can affect the physical properties of hydrogels formed from it [87]. The alginate used for this 
study has been reported to have low viscosity, low molecular weight (~50 kDa), and an M/G 
ratio of 1.67 [129]. Previous studies have found that hydrogels made with high M/G ratio 
alginate showed a higher swelling rate and higher solute leakage than low M/G ratio when stored 
at neutral pH [151, 155, 156]. Also, low molecular weight or low viscosity alginate with low G 
content produce unstable and weak hydrogels. Since the calcium ions only form complexes with 
G blocks of alginate, alginate with low G content forms less ionic bonding with calcium [73], 
which creates more flexible and elastic hydrogels for ion flux but increases the swelling rate 
when equilibrated with neutral buffer [157]. 
The present study reveals that all microspheres prepared with high M/G ratio alginate 
have high BSA release rates during the time course of the release study (Figure 2.6), which 
suggests high swelling properties of microspheres when stored in PBS at pH 7.4. Alginate 
microspheres prepared with 10% CaCl2 showed slower BSA release and a reduced burst effect 
during the earlier stage, possibly due to the increased permeability of microspheres. However, 
the releases of BSA rose to higher levels and reached a plateau more quickly despite the amount 
of CaCl2 used during the later stages of release. The results indicate that increasing the 
crosslinking degree of alginate microspheres could diminish initial burst effects and delay the 
protein release for a short period of time but could not reduce water diffusion in the long run, if 
alginate with low viscosity and low G contents is used. 
The effect of CaCl2 concentration used in the alginate droplet solidification process on 
the size of microspheres has been studied. Earlier studies have showed that there are shrinkage 
effects induced by calcium ions on bulk alginate hydrogels upon ionic crosslinking [87, 151, 
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152]. Syneresis of alginate hydrogels has been found to be greater when the concentration of 
calcium ions is higher. More available calcium cations permit a higher degree of ionic 
interactions between alginate molecules and cations, which induces conformational changes of 
the alginate polymer. This may be the cause of contraction and dehydration of alginate hydrogels 
given enough time for calcium ions uptake by hydrogels.  
A similar syneresis effect was observed in this study when the concentration of CaCl2 
used for gelation was increased. The diameters of alginate microspheres solidified with 10% 
CaCl2 are significantly smaller than 1% CaCl2 (Table 2.2). Figure 2.1 shows that there is a higher 
degree of shrinkage with all alginate microspheres prepared with 10% CaCl2 than 1% CaCl2, 
indicating the size of microspheres can be reduced by strengthening the syneresis of alginate 
polymers. Also, the size or size distribution of alginate microspheres could be controlled by the 
amount of calcium ions used for gelation process, although the syneresis process cannot be 
precisely regulated. In general, higher concentration of CaCl2, when used as external calcium 
source, is expected to increase the syneresis of alginate hydrogels at the expense of losing the 
internal polymer structures of the alginate. 
4.4. Effect of stirring speed 
Another aspect of the emulsification process affecting the size and shape of microspheres 
is the shear force. In the current study, shear force is determined by the stirring speed.  Past 
studies aiming at investigating different emulsion parameters have shown that increasing the 
stirring speed could reduce the mean diameters of the microspheres that are produced [58, 158, 
159]. A high stirring speed can provide more dispersive force and turbulent stress, which tend to 
break up the dispersed emulsion droplets [160]. Figure 2.3 and 3.2 show alginate microspheres 
prepared with 10% CaCl2 but using different emulsion process. The size range of alginate 
microspheres in Figure 2.3 are estimated to be 1 – 13 µm, while in Figure 3.2 are 0.5 – 3 µm. 
The alginate to oil volume ratio used is 1:4 in Chapter 2, and 1:3.3 in Chapter 3. It was found 
that the volume ratio between dispersed phase and continuous phase does not affect the diameter 
of emulsion droplets significantly for long term mixing [161]. Also, these ratios only have small 
variations between the two emulsion processes, thus it is not considered as the major cause of the 
reduced microsphere size. The decrease in microsphere diameters and narrow size distributions 
are mostly caused by the increase in dispersion force during the emulsification process. 
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Since both emulsification processes were done by mechanical stirring using stir bars, the 
overall volume of the emulsion mixture is important for effective mixing. Previous study has 
demonstrated that emulsion droplet size is independent on the emulsion volume if mixing speed 
is extremely high, such as 15,000 rpm [159]. Nevertheless, the stirring mechanism used in this 
study was the use of magnetic stir bars rotating at a much lower speed; thus, the total emulsion 
volume became a factor for the size of emulsion droplets. A large mixing volume could create 
more resistant force against stir bars, which causes reduction in dispersive force throughout the 
mixture. Also, it is highly likely that the stir bars cannot produce enough turbulent stress to 
create evenly distributed force throughout the emulsion mixture, which leads to the formation of 
unevenly sized emulsion droplets. When the emulsion volume was scaled down from 50 mL to 1 
mL and the stirring speed increased from 1200 rpm to 1300 rpm, smaller and monodispersed 
microspheres were obtained. This suggests that the movement of stir bars was less restricted by 
the viscous emulsion mixture and turbulent stress was relatively uniformly distributed 
throughout the mixture, which all contribute to the formation of small and uniform alginate 
microspheres. In fact, the fragmentation of emulsion droplets occurs when the shear force is 
larger than cohesive force of the droplets, and the size of microspheres is directly related to the 
size of emulsion droplets [162, 163]. These results indicate that the size and size distribution of 
microspheres formed using emulsion techniques are strongly influenced by the magnitude and 
distribution of dispersive forces throughout the emulsion mixture. Past experimental results also 
show that microspheres prepared with high stirring speed had smaller burst effects and sustained 
release [164].  
4.5. Loading methods 
Two methods were used to load BSA into alginate microspheres: incorporation and 
incubation methods. In the incorporation methods, BSA was added to the alginate solution prior 
to the emulsification and gelation process, and the incubation methods involve immersion of pre-
synthesized alginate microspheres into a BSA solution with a low concentration of sodium. 
Table 2.3 shows the encapsulation efficiency of BSA, and Figure 2.5 compares the effects of two 
protein loading methods on release profiles for alginate microspheres prepared with 1% and 10% 
CaCl2.  
60 
 
Despite of amount of CaCl2 used for gelation, the encapsulation efficiency for BSA is 
significantly lower and the release of BSA is more rapid for incubation methods than for 
incorporation methods. The incubation methods permit uptake of proteins by alginate 
microspheres due to protein concentration gradients and surface adsorption, while allowing 
partial decrosslinking of alginate microspheres using sodium ions. Using the incubation methods, 
alginate microspheres prepared with 10% CaCl2 showed lower loading and encapsulation 
efficiency of BSA than 1% CaCl2. This result could be explained by the lower permeability of 
highly crosslinked microspheres, which limits the amount of BSA that can diffuse into gelled 
microspheres.  
For all microspheres loaded using incubation methods, the release profiles show higher 
release at the beginning stage, which may be caused by dissolution of BSA adsorbed onto 
microspheres or weakening of microsphere interior structures during incubation. Although the 
incubation methods eliminate possible BSA loss during the preparation process, the BSA loaded 
into or adsorbed onto microspheres during immersion is lower than expected. In fact, the 
incubation methods are more suitable for loading proteins with an isoelectric point equal to or 
higher than neutral pH [105]. Wells et al. [105] reported that immersing alginate microspheres in 
a protein solution with 0.15% NaCl could efficiently entrap high pI proteins due to a higher 
degree of ionic interaction between negative alginate and positive proteins. In the research of 
Wells, alginate beads produced by extruding alginate solution into CaCl2 solutions were used to 
test the encapsulation efficiencies of two protein loading methods. However, the alginate 
microspheres produced by the emulsion technique in this study showed similar results regarding 
BSA encapsulation efficiency using the two loading methods. Since BSA is an electronegative 
protein at pH 7, the ability of alginate microspheres to attract BSA is dramatically reduced, and 
the ability of BSA to diffuse into the microsphere cores is limited. 
On the other hand, the incorporation method of protein loading relies on protein 
interaction with alginate while mixing, and retention of protein by alginate polymers in the 
emulsification and washing process. The unsatisfactory encapsulation efficiencies of BSA 
prepared using incorporation methods (Table 2.3) could be caused by unevenly dissolved BSA 
powder in the alginate solution and by large BSA loss during the emulsification and washing 
process. However, the IgG encapsulation efficiency reached 89.4 % (Table 3.1) compared to 7.8% 
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for BSA both using incorporation loading methods. Apart from the improvement in microsphere 
preparation process, the well dissolved IgG-alginate solution and the properties of the proteins 
themselves could be critical causes. The Dylight 800-conjugated IgG was prepared in solution 
form and was evenly dispersed into 5% alginate solution before the beginning of the 
emulsification process. Also, the ionic interaction between electronegative alginate and 
electropositive IgG increases the possibility of IgG retention in alginate matrices, and thus 
decreases the loss of IgG during microsphere preparation. In general, incorporation loading 
methods provide higher encapsulation efficiencies if protein loss during preparation can be 
minimized, and the physical and chemical properties of proteins need to be considered if 
incubation methods are used. 
4.6. Release properties of alginate microspheres in different release media 
The release of proteins mostly depends on the diffusion rate of protein through alginate 
matrices and dissolution of alginate microspheres. The protein diffusion rate is mainly related to 
the properties of proteins themselves, and the dissolution of alginate microspheres is caused by 
the bulk erosion and decrosslinking. The diffusion of water molecules into alginate gels is faster 
than the surface degradation of alginate polymer, which leads to swelling of hydrogels. As 
mentioned before, the swelling is largely dependent on the molecular weight, viscosity, and G 
contents of alginate, where the decrosslinking process is not only related to alginate chemical 
properties, but also the crosslinking degree and ions surrounding the hydrogels. Moreover, the 
decrosslinking process accelerates hydrogel gel swelling. The replacement of calcium ions in the 
alginate matrices with monovalent ions and the sequestration of calcium ions by anions lead to 
decrosslinking of alginate microspheres. Therefore, the ionic strength and composition of the 
medium influence the rate of decrosslinking and degree of swelling, requiring careful 
consideration of the choice of release media. 
At the earlier stage of this study, 10 mM PBS at pH 7.4 was used as the release medium, 
and 20 mM TBS at pH 7.4 was used for later studies, since the release of IgG from alginate 
microspheres prepared by emulsion/external gelation technique in TBS plus extra calcium ions 
has not been characterized. Although the emulsification conditions used to fabricate alginate 
microspheres and the encapsulated proteins are different in the earlier and later stage of these 
studies, these release profiles are still comparable in terms of overall release time. The protein 
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release studies done in TBS with 2 mM CaCl2 showed more sustained release than in PBS. A 
complete BSA release was observed within 5 to 6 hours in PBS despite the amount of CaCl2 
used for gelation, where IgG release lasted 160 hours in TBS for non-coated alginate 
microspheres. 
Previous experiments have revealed that alginate matrices swelled extensively if the 
release medium contained sodium ions, since calcium ions were replaced by sodium ions quickly 
and soluble sodium alginate was formed [133]. Since both PBS and TBS have sodium ions, the 
decrosslinking of alginate microspheres due to sodium and calcium ion exchange is not expected 
to be significantly different between the two media. The fast protein release and extensive 
swelling effect in PBS are more likely due to the sequestration of calcium ions in microspheres 
by the phosphate groups in PBS, which leads to formation of insoluble calcium phosphate. The 
high affinity between calcium ions and phosphate groups accelerates the decrosslinking process 
of alginate microspheres, which in turn leads to rapid swelling of microspheres and shortened 
release time.  
However, the IgG release in TBS plus 2 mM CaCl2 was tremendously extended and the 
initial burst of microspheres was reduced. This phenomenon could be explained by the lack of a 
sequestration agent with high calcium affinity and the addition of calcium ions. The purpose of 
adding 2 mM CaCl2 is to mimic the physiological calcium concentration in DMEM tissue culture 
medium, which normally contains 1.8 mM CaCl2 [165, 166]. The differences between the 
swelling properties of alginate hydrogels in PBS and Tris-HCl at pH 7.4 were studied, and our 
results demonstrated that swelling in PBS was mainly due to sodium and calcium ion exchange 
and formation of calcium phosphate, where swelling in Tris-HCl was caused by hydrolysis of 
hydrogels [167]. The current study showed the dependence of protein release profiles on the 
release media with the presence of sodium ions. The phosphate ions in PBS are likely to form 
precipitates with calcium ions. On the contrary, organic TBS has lower affinity to crosslinking 
calcium ions, which leads to a slower decrease in crosslinking density of microspheres despite 
the occurrence of sodium and calcium ion exchange. Thus, the composition of buffer plays an 
important role in protein release kinetics. 
The release of protein from alginate cylinders containing embedded microspheres was 
examined in DMEM and TBS plus 2 mM CaCl2 in Chapter 2 and 3, respectively. It has been 
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stated that PBS is commonly used as a release medium, but the release profiles of proteins in 
other media are also worth to study, since no one medium can exactly reproduce in vivo 
conditions. The intention of using DMEM as the release medium was to more closely mimic the 
ion profile of physiological conditions. BSA release was more rapid in DMEM than was IgG in 
TBS, possibly due to the complex ingredients in DMEM. The DMEM solution for cell culture 
consists of amino acids, vitamins, and inorganic salts [165], which all could form complexes 
with calcium ions. The crosslinking calcium ions in microspheres are expected to undergo ion 
exchange with monovalent ions or form precipitates with these inorganic salts. Although the 
results obtained from this study are inconclusive to determine the effect of DMEM has on 
alginate hydrogel dissolution and decrosslinking, protein release is expected to be faster in 
DMEM than in TBS plus 2 mM CaCl2. 
4.7. Properties of proteins 
Although the two types of microsphere were prepared under different conditions, 
comparing the release profiles of BSA- and IgG-loaded microspheres, they illustrate that BSA-
loaded microspheres have more rapid release and shorter overall release time. The large 
differences in the release kinetics may be explained partly by the distinctions in protein types. 
The diffusion rate of protein through the alginate microspheres and matrices is determined in part 
by the properties of proteins themselves, such as molecular weights, sizes of three-dimensional 
structures, isoelectric points, and interactions between the proteins and the alginate polymers 
[131, 135]. 
The average molecular weights of BSA and IgG are 67 and 155 kDa, respectively. 
Experiments studying the release of proteins ranging from 17.8 to 156 kDa reported that the 
release from alginate microspheres decreases as the protein molecular weights increases [168]. 
Large proteins, such as IgG, have slower diffusion rate than proteins small in molecular weights, 
since the permeability of alginate microspheres become a more critical factor for high molecular 
weight-protein diffusion. 
Also, it has been found that size of 3-D structure of proteins (for example the stokes 
radius) has effects on the diffusion coefficients in passing through permeable gel membranes 
[131]. Other studies suggest that the 3-D structure of BSA is ellipsoid and that it has a high 
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deformation capacity, which increase its diffusion rate through chitosan coated alginate beads 
[135].  By contrast, IgG has a more extended three-dimensional shape, possible leading to more 
retarded diffusion through a hydrogel. 
Previous results were obtained from alginate hydrogels or spheres produced by different 
methods, although IgG release from small and uniform alginate microspheres produced by the 
emulsion technique has not previously been reported. The previous findings are consistent with 
the results of this study; IgG diffuses more slowly than BSA due to the high hydrodynamic 
volumes of IgG, whether from chitosan coated or uncoated alginate microspheres. Another 
property of proteins can also be used to explain the differences in diffusion rates. The net charges 
of proteins are different at a given pH due to different pI values of each protein. BSA has a pI of 
4.9, and IgG has a pI of 7.1 [169], which results in a more electronegative charge on BSA in a 
solution buffered at pH 7.4. The burst release profiles of electronegative BSA have been 
observed in alginate microspheres crosslinked with CaCl2 and alginate composite microspheres 
[139, 170]. The negative charges on BSA impose a repulsive force on negatively charged 
carboxyl groups of alginate at physiological pH; as a result, alginate microspheres retain BSA for 
a shorter time. On the other hand, IgG presents more accessible positive charges, which leads to 
more ionic interactions with alginate polymer inside the microspheres. Therefore, the release 
profile of IgG was lengthened and the initial burst release from microspheres was reduced due to 
the larger molecular weight and size, and positive net charges of IgG. 
4.8. Protein detection methods 
Two protein detection methods were used in this study. The BSA release was detected 
using the Bradford assay in Chapter 2. According to the manufacturer’s manual, the Bradford 
reagent has a lower detection limit of 1 µg/mL protein. The BSA released during the later stage 
of the release studies could be undetectable due to the fact that the amount of BSA protein used 
in loading microspheres was small and BSA-alginate microspheres have low encapsulation 
efficiency. After the burst period in PBS, the BSA released in the medium was approaching the 
lower detection limit of the Bradford assay. The Bradford assay is dependent on the protein 
tertiary structures and is easily affected by the detergent concentration in the assay [171]. Since 
the possible denaturation of BSA during the preparation of microspheres and the possible 
residual presence of Span 80 in the freeze-dried microspheres were not analyzed, the suitability 
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of using Bradford assay to detect BSA release in this experiment cannot be determined although 
it has been commonly used for protein detection in studying microsphere release [172-174]. 
The DyLight 800-IgG was detected by a LI-COR infrared imaging system in Chapter 3. 
The Odyssey infrared imaging system can detect near-IR dye-conjugated proteins in amounts as 
low as 1 nanogram [175], which provides a wide range of protein detection and reliable 
quantification. However, the effect of emulsification and the washing process on the stability of 
the Dylight 800 dye was not examined; rather the dye conjugated to IgG was assumed to be 
stable throughout the experiments. The effects of buffer and temperature on the fluorescent of 
dyes were taken into account by making standards of Dylight 800-conjugated IgG in the release 
medium and keeping these standards under the same condition as the IgG-loaded alginate 
microspheres. The experimental results show that the Dylight 800-conjugated IgG could be 
detected at least as low as 50 ng/mL in TBS at pH 7.4.  
The methods for sampling protein release media were different for BSA- and IgG-loaded 
microspheres. When the BSA release media were analyzed, all of the supernatants were taken for 
Bradford assay after centrifugations, and were replaced with fresh buffer. The method of 
replacing all release medium maintains a large concentration gradient of BSA between the inside 
and the outside of the alginate microspheres, which promotes BSA diffusion toward the outside 
of microspheres. Therefore, the rapid BSA release was partially driven by the maintained high 
BSA concentration gradients created by replacing the release medium. In the case of IgG release, 
only 1% of the release medium was taken for fluorescent detection, which was considered to 
cause insignificant changes in the accumulated IgG concentration in the release media, and 
thereby more closely model likely release conditions in practice. 
4.9. Effect of chitosan coating 
Protein-loaded alginate microspheres were coated in 0.1% chitosan solution to lengthen 
the time span of protein release. In Chapter 2, complete BSA release was extended from 6 hours 
for uncoated microsphere to 55 hours for chitosan coated microspheres. For the IgG-loaded 
microspheres, IgG was fully released from naked microspheres at 160 hours, while 
approximately 50% of IgG was released from coated microspheres at the same time. Coating 
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alginate microspheres with chitosan membranes has been previously demonstrated to reduce or 
control protein release [93, 112].  
Chitosan dissolved in diluted acetic acid is a polycationic polysaccharide, which 
complexes with polyanionic alginate. The pH of chitosan solution was adjusted to 5, at which the 
alginate is net negatively charged and the chitosan is positively charged [111]. This adjustment 
in pH ensures a strong electrostatic interaction between chitosan and alginate, and consequently a 
stable chitosan membrane can be formed around alginate microspheres. The release profiles of 
BSA and IgG from chitosan coated alginate microspheres demonstrate that the chitosan coating 
can reinforce alginate microspheres and effectively retard protein release. 
4.10. Controlled release 
The experimental results show that the release of protein from naked protein-loaded 
alginate microspheres is rapid and exhibits an unavoidable initial burst. These release profiles 
suggest that the protein release is largely dependent on the dissolution of alginate, ion diffusion 
rate, and properties of microspheres. Using CaCl2 as crosslinker has the benefits of low toxicity, 
fast gelation time, and easy diffusion of calcium ions into microspheres. However, the 
disassociation of ionic bonding is fast and can be easily broken by ion exchange. The nature of 
ionic interaction between calcium and alginate leads to fast swelling and rupture of initially 
stable microspheres in neutral buffers. It has been demonstrated that the swelling and dissolution 
rate of alginate microspheres can be reduced by increasing the crosslinking degree. Development 
of advanced preparation methods can result in fabrication of uniform and small alginate 
microspheres, which may improve the protein release. Additionally, the chitosan coating 
generally enhances the microspheres and reduces the protein release, which achieves sustained 
release. The chemical properties of proteins can also be a critical factor for realizing sustained 
release. 
4.11. Microspheres incorporated within alginate scaffolds 
The release behaviours of BSA and IgG from microspheres incorporated within alginate 
cylinders are shown in Figure 2.7 and 3.4, respectively. The release profiles of BSA have an 
obvious initial burst release, and then undergo a slower release until complete release was 
reached at approximate 50 hours. As expected, the BSA release from microspheres prepared 
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using incubation methods was more rapid than when using incorporation methods (Figure 2.7). 
After the initial 7-hour-burst release, 60-70% of BSA was released from scaffolds with 
microspheres loaded using incubation methods, whereas 35-45% of BSA was released from 
microspheres loaded using incorporation methods. This observation corresponds to the release 
kinetics of alginate microspheres in PBS, and could be explained by the BSA distribution in the 
alginate microspheres described in the previous section. The release of IgG went through a 
similar trend but the initial burst release was smaller, and the overall release time was prolonged. 
The initial burst release of IgG was retarded to about 15 hours, and about 3-13% of IgG was 
released from scaffolds after 50 hours in different cases.  
The protein release from scaffolds containing microspheres was affected not only by the 
release of proteins from the microspheres themselves, but also by the properties of the alginate 
hydrogels. The degradation rate, the dissolution rate, swelling effects of hydrogel scaffolds, and 
the diffusion rate of protein though hydrogels could influence the protein release kinetics. The 
degradation rate of ionically crosslinked alginate polymer is slow, rather calcium diffusion out of 
the hydrogels and alginate dissolution occur first in vitro [87, 129]. Given the two-week 
experimental time, the weakening of alginate cylindrical scaffolds is mainly caused by diffusion 
of water molecules into gels and exchanges of sodium and calcium ions, which leads to swelling 
of and dissolution of hydrogels. Changes in the physical properties of alginate hydrogels, such as 
weakening in strength and enlarged pore size, could accelerate the diffusion rate of proteins from 
hydrogels. However, it is obviously that the diffusion rate of proteins was effectively reduced 
and remained stable by embedding microspheres in alginate gels. It is possible that the alginate 
cylindrical scaffolds have a highly crosslinked exterior, which sufficiently lowers the 
permeability of gels, or the transport of proteins inside the gels was not notably affected by the 
ion diffusions and alginate dissolution. Since the dissolution rate of alginate and the diffusion 
rate of protein were not investigated (either in PBS or in TBS plus 2 mM CaCl2 at 37 °C) in the 
current study, the contribution of each cause cannot be concluded in this study. Nevertheless, it 
has been reported that proteins with high molecular weight and radius, such as IgG, have a 
slower diffusion rate in water [131], and the alginate hydrogels crosslinked by highly 
concentrated CaCl2 showed low membrane permeability and a more prolonged release rate [152, 
176]. Therefore, it can be assumed that a higher degree of crosslinking of alginate hydrogels has 
68 
 
the ability to hinder the transport of proteins inside the gel but the movement of proteins is also 
based on the properties of proteins.  
The causes of differences in the release profiles of BSA and IgG can be summarized in 
following points. First of all, the changes in preparation process of alginate microspheres and the 
nature of proteins that have been mentioned before. Secondly, the release of BSA-loaded 
alginate scaffolds was examined in DMEM and in TBS + 2 mM CaCl2 for IgG-loaded scaffolds. 
Although the concentration of CaCl2 is similar in these two release media, the sequestration of 
crosslinking calcium ions by different anions in DMEM accelerates the swelling and dissolution 
rate of microspheres and scaffolds. Thirdly, the BSA-scaffolds were gelled in 1M CaCl2 for 12 
hours, compared with 15 minutes for IgG-scaffolds. The long gelation time may induce the 
release of BSA during storage time, which leads to loss of BSA during processing. As discussed 
before, the external gelation methods involving soaking in CaCl2 solution cause internal polymer 
rearrangements of alginate and protein; thus, the BSA molecules are more likely to be relocated 
close to the surface of microspheres. The internal structural changes in alginate microspheres 
maybe be represented in the release profiles of BSA. Lastly, the BSA-microsphere-incorporated 
scaffolds were prepared with dried microspheres, and the IgG ones were prepared with wet 
microspheres. It has been documented that dried alginate microspheres swell more substantially 
than wet ones in PBS [134]. The large swelling rate of dried microspheres could destroy the 
internal polymer network of gelled alginate scaffolds. The rupture and dissolution of BSA-
alginate scaffolds could be expedited by the volume expansion of microspheres. As a result, the 
IgG-loaded microsphere-incorporated alginate scaffolds exhibited a lower initial burst effect and 
a sustained release. 
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Chapter 5. Summary, conclusions, and future work 
5.1. Summary and conclusions of research 
Alginate microspheres have been prepared using emulsification and external gelation 
methods. Various emulsification parameters, such as CaCl2 concentration, stirring speed, total 
emulsion volume, and alginate-to-oil ratio, were investigated to produce small and uniform 
alginate microspheres. All alginate microspheres produced have a spherical shape and smooth 
surface; and the size and size distribution of microspheres can be controlled by using different 
process parameters. 
Alginate microspheres produced using large emulsion volume and smaller dispersing 
force leads to large mean diameters and wide size distribution. The size analysis and SEM photos 
of microspheres suggest that high crosslinking degree and dispersing force can increase the 
probability of fabricating small and uniform microspheres. 
Two proteins, BSA and IgG, were chosen as model proteins for preparing protein-loaded 
alginate microspheres. BSA was used as a reference for small proteins with low pI value and IgG 
was used as a reference for large proteins with high pI value. Protein-loaded alginate 
microspheres were successfully prepared, and two protein loading methods, incubation and 
incorporation, were studied using BSA. It has been established in this study that the 
incorporation method can achieve high encapsulation efficiencies for both BSA and IgG, and 
that the incubation method is not suitable for low pI proteins. The protein loading method should 
be chosen for the chemical properties of protein so that the retention of proteins by alginate 
polymer can be maximized. 
The effects of CaCl2 concentrations and protein loading methods on the release kinetics 
of BSA were also examined in vitro. The BSA release profiles of alginate microspheres loaded 
with incubation methods had a more substantial initial burst followed by a more rapid release, 
comparing to BSA loaded by incorporation methods, which further emphasizes that incubation 
loading methods are not suitable for BSA. Increasing the CaCl2 concentration for external 
gelation can produce more stable microspheres, and thus, lengthen the BSA release time. On the 
other hand, IgG release from small and uniform alginate microspheres was slow. This sustained 
IgG release was possibly due to improvement in uniformity of microspheres, evenly dispersed 
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IgG in alginate solution prior to emulsion process, and higher degree of alginate-protein 
interaction. 
The effect of chitosan coating on the BSA and IgG release was also studied in vitro. In all 
cases, chitosan coating reduced the initial burst and retarded the protein release. The ion contents 
in the release media also have influences on the in vitro release behaviours of proteins. It is clear 
that release medium containing ions with high-calcium affinity can accelerate protein release. 
The release of BSA and IgG from alginate scaffolds containing incorporated 
microspheres was observed. Results suggest that the release of protein relies on a combined 
diffusion mechanism of protein diffusion from microspheres and protein movement within the 
scaffolds. Therefore, the dissolution, swelling, and diffusion properties of both alginate 
microspheres and hydrogels are critical for the release kinetics. It was observed that scaffolds 
prepared using highly crosslinked wet microspheres, optimal scaffold gelation time, and high 
crosslinking density can lower the initial burst effect and achieve prolonged protein release. 
5.2. Future work 
As the emulsification and external gelation process has been proven to produce spherical 
alginate microspheres, the optimal emulsifier concentration, the CaCl2 concentration, the stirring 
speed, and the gelation time should be further investigated to ensure the highest productivity and 
encapsulation efficiency of protein-loaded alginate microspheres. The influences of chemical 
properties of alginate such as M/G ratios and molecular weights on the dissolution and swelling 
rates remain to be examined, since the protein release mechanism depends on the stability of 
microspheres. External gelation methods are known to change the internal alginate and protein 
distribution in microspheres upon gelation, so the internal structure of prepared alginate 
microspheres should be studied to determine the optimal gelation methods. Also, the current 
study demonstrates that chitosan coating of alginate microspheres can control the protein release. 
Therefore, the effects of chitosan with different molecular weight on the protein release kinetics 
need to be studied to gather more data on how to use chitosan coatings to more precisely control 
the protein release. 
It has been shown that embedding protein-loaded microspheres within alginate scaffolds 
has the ability to reduce the initial burst and retard the protein release. Results reveal that protein 
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release from this kind of scaffold strongly relies on the properties of both the microspheres and 
the larger scaffolds. It can be concluded that the swelling and dissolution of alginate in 
microspheres and scaffolds have interactive effects on each other. This type of release behaviour 
imposes complications on controlling protein release; from another point of view, the protein 
release kinetics can be doubly controlled by optimizing the properties of both microspheres and 
scaffolds. As a consequence, the effects of percentages of microspheres in scaffolds, the 
chemical composition of scaffolds, the pore size of microspheres and scaffolds, the internal 
network of scaffolds, and the gelation methods on controlling the protein release should be 
further investigated. Also, the release medium used for in vitro studies should be considered 
carefully, and in vitro studies should be designed to closely mimic in vivo conditions. Due to the 
nature of proteins, different proteins represent different release kinetics. Strategies to encapsulate 
multi-proteins in alginate microspheres could be investigated to deliver multiple proteins at 
different time point and concentration in a controllable manner. 
In order to be sure that this technology will ultimately have useful clinical applications, 
the bioactivity of the encapsulated protein should be examined. Since the protein was added into 
alginate solution before emulsion and alcohol washing processes in the incorporation loading 
method, the possibility of denaturation or breakdown of the protein exists. The biological 
function of a protein is strongly dependent on the native structure of the protein, and therefore, it 
is necessary to test the stability and biological activity of the released protein. The protein can be 
isolated from an in vitro release assay and the molecular weight of the released protein can be 
determined by sodium dodecyl sulfate polyacrylamide gel electrophoresis. If the breakdown of 
protein is not observed, an antibody assay can be used to analyze the specific biological activity 
of the protein. Other indirect testing method, for example, using the protein loaded microspheres 
in in vitro or in vivo bioassay experiments, can also be used. For example, the protein biological 
functions can be measured by analyzing the ability of the released protein to carry out known 
cellular functions or other aspects of the tissue regeneration process that are expected from the 
released protein. 
Once the release profiles of the model protein from optimized alginate microspheres and 
the protein bioactivities are carefully studied, alginate microspheres or scaffolds loaded with a 
therapeutic protein could be implanted for in vivo studies. The effects of the delivered functional 
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protein in the target site should be examined. The activities of protein synthesis, the 
inflammation response, and the growth of tissues at the implantation site should be monitored to 
test the functions of the protein carrier.  
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